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ABSTRACT 




Neurotransmitter:sodium symporter (NSS) proteins, the targets of antidepressants and 
psychostimulants, clear neurotransmitters  from  the synaptic cleft in a Na+-coupled 
transport mechanism. Transport is thought to occur via conformational rearrangements 
that alternately expose the substrate-binding site to each side of the membrane, but little 
is known about the mechanism by which ligand binding coordinates motions at the two 
faces. In this dissertation, single-molecule fluorescence resonance energy transfer 
(smFRET) techniques are used to image the dynamics of the prokaryotic NSS LeuT with 
sufficient resolution to describe the conformational states at both the intra- and 
extracellular faces for the first time. We found that the two sides do not move as a rigid 
body, contrary to popular models, and that previously undetected intermediate states are 
associated with transport activity. We also describe how ions and substrates influence 
conformational dynamics to create a productive transport cycle.  
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1. INTRODUCTION 
 
1.1 The physiology of neurotransmitter transporters  
 
In the human brain, 
cognitive, behavioral, and 
emotional processing is 
mediated by 
approximately 10 billion 
neurons communicating 
with each other at 
synaptic junctions. 
Neurons form networks 
that process information 
in parallel, with each 
neuron forming on 
average 10,000 synapses. 
An action potential in a pre-synaptic neuron induces it to release neurotransmitters from 
synaptic vesicles into the extracellular space, which diffuse across the synapse and bind 
to ligand-gated ion channels or receptors primarily localized on post-synaptic neurons, 
either exciting or inhibiting these downstream neurons (Figure 1.1).  Neurotransmitters 
include the amino acids glutamate, GABA and glycine, as well as biogenic monoamines 
such as dopamine, serotonin and norepinephrine.  
Neurotransmitter transporters clear neurotransmitters from the synaptic cleft by 
taking them back up into the pre-synaptic cell where they are repackaged into synaptic 
Figure 1.1 Neurotransmission at a neuronal synapse. 
Neurotransmitters are released from presynaptic vesicles into the 
synaptic cleft and bind to receptors on the postsynaptic cell 
membrane. Neurotransmitter transporters in astroglial or 
neuronal membranes clear neurotransmitters from the synaptic 
cleft by co-transport with Na+ down its electrochemical gradient. 
Figure from2 
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vesicles, thereby modulating the spatial and temporal characteristics of signaling as well 
as recycling neurotransmitters for future use 2,7,8. These secondary active transporters are 
able to concentrate neurotransmitter inside the cell by coupling uptake to symport of Na+, 
driven by the physiological Na+ gradient generated by the action of Na+/K+-ATPases. 
Thus, the concentration of neurotransmitters in the synapse is returned to a low level after 
each signaling event, ensuring that further rounds of neurotransmitter release will be 
detected. 
Neurotransmitter transporters belong to two major families 2. Glutamate transporters 
belong to the solute carrier 1 (SLC1) family, also called excitatory amino acid 
transporters (EAATs). The transporters for the majority of neurotransmitters, including 
dopamine, serotonin, norepinephrine and GABA (DAT, SERT, NET, and GAT) belong 
to the SLC6 family, commonly referred to as neurotransmitter:sodium symporters 
(NSSs), and are dependent on Cl- as well as Na+.  
Many medications target the NSSs for biogenic amines, including antidepressants 9,10 
and drugs to treat attention deficit hyperactivity disorder (ADHD)8 or neuropathic pain 11, 
as well as the widely abused psychostimulants cocaine and amphetamine 12. In addition, 
NSSs for GABA and glycine are promising targets for the treatment of epilepsy 13 and 
anxiety disorders 14, or schizophrenia 15, respectively. Many psychiatric and neurological 
disorders have been linked to dysfunctions in neurotransmission, including schizophrenia 
15, depression 16, ADHD 16, obsessive-compulsive disorder 17, autism spectrum disorders 
18, Parkinson’s disease 16, epilepsy 13, and migraines 19. Thus, a detailed understanding of 
the NSS transport mechanism and modes of regulation is of great clinical importance in 
order to design novel modulators of NSS function. 
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1.2 The prokaryotic NSS homolog LeuT as a model system to study NSS structure 
and function 
 
The eukaryotic NSS proteins are challenging to express at high levels for purification 
and study, due in part to their lability and heterogeneities in post-translational 
modifications 20.  Prokaryotic NSS homologs have proven to be valuable model systems 
for understanding the NSS transport mechanism 20. A Na+-coupled amino acid transporter 
from the thermophile Aquifex aeolicus was crystallized in 2005 at 1.65 Å resolution 4, 
providing the first high-resolution structure of a member of the NSS family. The structure 
revealed protomers ~70 Å tall and ~48 Å wide with 12 transmembrane helices (TMs) in a 
novel fold, with an inverted topological repeat relating TM1-5 and TM6-10 by a pseudo 
two-fold axis of symmetry (Figure 1.2).  
In the crystal structure, the substrate leucine was bound in a central site, as were two 
Na+ ions, consistent with the transport stoichiometry 4, leading to the name LeuT (leucine 
transporter). LeuT transports a variety of hydrophobic amino acids, including alanine, 
Figure 1.2 Structure of LeuT. Left, Topology, with transmembrane domains labeled 1-12, 
extra- and intracellular loops (ELs and ILs), and the inverted repeats shown as pink and blue 
triangles. The unwound regions of TM1 and 6 form the binding sites for leucine  (yellow 
triangle) and two Na+ ions (blue circles). Right, Crystal structure showing density for bound 
leucine and Na+ ions. Figure adapted from4. 
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which is in fact transported much faster than leucine 4,21,22. However, transport of all 
substrates is orders of magnitude slower than eukaryotic NSSs, with a turnover time at 
room temperature of minutes 3,21 rather than ~ 1 sec 23-25. This is likely due to the fact that 
LeuT is derived from a thermophilic organism adapted to extremely high temperatures, 
which leads to its stability.  
The use of LeuT as a model system has significantly advanced our understanding of 
the NSS mechanism of transport, the basis of substrate and ion specificities, and 
mechanisms of pharmacological inhibition. Although the overall sequence homology 
between LeuT and eukaryotic NSS is only ~20%, the sequence homology in 
transmembrane regions is much higher, particularly TM1 and 6, and many functionally 
important residues are strictly conserved 26. The Drosophila DAT (dDAT) was 
crystallized in 2013 in complex with the antidepressant nortriptyline 27, confirming the 
similarities in overall structure between LeuT and eukaryotic NSS.  
Unlike the eukaryotic NSSs, LeuT is not Cl--dependent, but instead antiports protons 
28,29. In spite of this difference, LeuT was used as a model system to generate predictions 
about the location of the Cl- binding site in the eukaryotic NSSs 5,28,30, which were 
subsequently confirmed by crystal structures of dDAT bound to Cl- 27. Like the 
eukaryotic NSS, LeuT is inhibited by tricyclic antidepressants (TCAs) 31,32 and selective 
serotonin reuptake inhibitors (SSRIs) 33, although antidepressants bind to different sites in 
LeuT compared to the eukaryotic NSS and exhibit different modes of inhibition: 
noncompetitive in LeuT 31-33 and competitive in eukaryotic NSSs 27,34-37. Nevertheless, 
the use of LeuT as a model system has provided insight into mechanisms of inhibition in 
NSSs. LeuT was crystallized in complex with the competitive inhibitor tryptophan in 
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2008 22, which appeared to sterically block closure of the extracellular gate, suggesting 
that this might be a general mechanism of competitive inhibition in NSSs. This prediction 
was verified by crystal structures of dDAT in complex with antidepressants and 
psychostimulants 27,35, demonstrating a similar outward-open conformation due to steric 
constraints.  
In the LeuT crystal structure, TM1 and 6 have interruptions of the helical structure 
approximately halfway across the membrane, exposing main-chain carbonyl and oxygen 
atoms that form direct interactions with Na+ and substrate (Figure 1.2) 4. Sequence 
alignment has shown that NSS amino acid transporters have a glycine in this region at 
position 24, while mammalian biogenic amine transporters have an aspartate, which 
presumably takes the place of the “absent” carboxyl group of the amine substrates 26. 
Two Na+ sites were identified within 6 Å of the bound leucine 4. The Na+ in the Na1 site 
directly coordinates the leucine, while the Na2 site is located ~7 Å below. The close 
proximity of the Na+ and substrate binding sites suggest a coupling mechanism in which 
Na+ binding to the unwound regions of TM1 and 6 organizes the substrate site. Other 
NSSs have varying substrate:Na+ stoichiometries, with the Na2 site more conserved 38,39.  
Although LeuT was crystallized with only one substrate bound, simulations have 
identified a second substrate binding site (S2) in the extracellular vestibule, ~11 Å above 
the central substrate site (S1); functional studies and smFRET data suggest that the S2 
site plays an allosteric role in the transport cycle 3,21. Radioligand binding assays in LeuT 
showed that leucine can be trapped in the S1 site, but is released by the addition of 
substrate in the absence of Na+, presumably by substrate binding to the S2 site and 
allosterically triggering inward release 21. Mutations in the putative S2 site have been 
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demonstrated to reduce the substrate binding stoichiometry from two to one, and to 
eliminate transport activity as well as substrate-induced smFRET intracellular dynamics 
3.  
The existence and functional role of the S2 site remains controversial 40,41, as no 
crystal structure has revealed substrate bound in this site. However, the detergent used for 
crystallization of LeuT, octylglucoside (OG), has been shown to occupy the S2 site, 
preventing S2 substrate binding 42.  Further contributing to the controversy, the effect of 
S2 site mutations on substrate binding stoichiometry depends on the methods of protein 
preparation. However, these discrepancies have also been shown to result from artifacts 
of detergent such as n-dodecyl β-D-maltoside (DDM), which at high concentrations can 
occupy the S2 site and block transport 42-44.   
 
1.3 The alternating access model of transport  
 
A widely accepted 
“alternating access” 
model proposes that 
the NSS transport 
cycle occurs through 
conformational 
changes that expose a 
central substrate 
binding site alternately 
to the outside and inside of the cell, where substrate is taken up and released, respectively 
Figure 1.3 Schematic of the alternating access mechanism. Based 
on crystal structures of (a) outward-open, (b) outward-occluded, and 
(c) inward-open LeuT.  Figure from 1. 
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45. Crystal structures of LeuT in different conformations have been interpreted as 
corresponding to states in this cycle (Figure 1.3).  
The first LeuT crystal structure was described as an outward-facing occluded 
conformation 4 because access from the intracellular side is closed off by a thick “gate” 
of 20 Å of compact protein structure, while at the outside face the substrate is occluded 
from the solution by only a thin gate of interactions between several residues, with a 
water-filled extracellular vestibule above. Highly conserved charged pairs and aromatic 
residues comprise portions of the gates at both faces 26.  
Substrate-free LeuT has 
subsequently been crystallized 
in conformations described as 
outward-open and inward-open 
(Figure 1.4), using 
conformation-specific 
antibodies and mutations to 
promote these states 1. Relative 
to the outward-facing occluded 
structure, the outward-open 
structure demonstrates hinge-like movements of TMs 1b, 6a and 2 away from the central 
substrate site, exposing it to extracellular solution. The authors interpreted the presence of 
bound Na+ ions as suggesting that Na+ bridges interactions between intracellular TMs, 
thereby maintaining an inward-closed state. The similarity between the substrate-free 1 
Figure 1.4 Crystal structures of LeuT in (a) outward-
facing and (b) inward-facing conformations. Figure 
adapted from 1.   
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and competitive inhibitor-bound 22 outward-open structures suggests that competitive 
inhibitors stabilize states accessed by the ligand-free transporter.  
The inward-open crystal structure demonstrates hinge-like movements of several 
helices at both faces, as well as shifts in extracellular loops (ELs). The major 
conformational change is a 45° movement of TM1a towards the membrane, exposing the 
central binding site to intracellular solution. At the extracellular face, TM1b and 6a tilt 
inwards and EL4 dips down into the extracellular vestibule, closing off the extracellular 
pathway, consistent with the alternating access model’s prediction that when one face is 
in an open state the opposite face should be in a closed conformation.  
The crystal structures suggest that the extracellular and intracellular faces of several 
helices move at “joints” created by the unwound regions, with binding and unbinding of 
ligands stabilizing the TMs in different conformations. However, little is known about the 
means by which ligands coordinate the motions at the two faces. Different models 
postulate either rigid-body movements of entire TMs 46, or local movements of the 
intracellular versus extracellular segments of flexible TMs 1.  
Based on the pseudo two-fold symmetry relating TM1-5 and TM6-10, as well as the 
organization of the first two helices of each repeat into a four-helix bundle that is tilted 
away from the scaffold helices in the outward-facing occluded crystal structure, forming 
an extracellular permeation pathway 4, it has been previously proposed 46,47 that this 
bundle moves as a unit in a rocking motion to form the intracellular permeation pathway 
with the corresponding TMs of the topologically inverted repeat.  Moreover, it was 
proposed that this bundle moves as a rigid body, forcing the opposite face to open when 
one face is in a closed conformation 46, which provided a compelling mechanistic basis 
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for the alternating access model. Prior to the crystallization of LeuT in additional 
conformations, this model was used to predict which residues lined the intracellular 
permeation pathway, and these predictions were consistent with cysteine accessibility 
studies in SERT 47. However, the subsequent crystal structures of LeuT in inward-open 
and outward-open states 1 showed that the extracellular and intracellular regions of some 
helices move to different extents, suggesting that they bend flexibly. If this is the case, it 
is uncertain how the movements of the two faces might be coupled to produce the 
alternating access mechanism.  
Cysteine accessibility and electron paramagnetic resonance (EPR) studies have 
provided additional information about the effects of ligand binding on the conformational 
states of LeuT. At the extracellular face, Na+ increased the accessibility and mobility of 
labeling sites in the extracellular vestibule (in TM1b, TM3, and EL4), suggesting an 
outward-open conformation with looser packing of the extracellular permeation pathway 
48,49. Double electron-electron resonance (DEER) indicated that Na+ promoted increased 
distances between EL6 and EL4, suggesting that an outward movement of EL4 is 
responsible for the exposed extracellular permeation pathway 48,49.  In addition, TM6a 
was shown to move away from TM3 and 5 49.   
In contrast, Leu in the presence of Na+ reduced accessibility and decreased mobility 
in the extracellular vestibule, suggesting closure of the extracellular permeation pathway, 
and DEER indicated shorter distances between TM12 and TM6a 48. In addition, EL6 
moved closer to EL4 48,49, and TMs 1b, 6a, and 7b moved closer to TMs 3 and 5 49, and 
these distance changes were > 5 Å larger than those predicted from crystal structures of 
outward-facing substrate-occluded versus substrate-free outward-open.  
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At the intracellular face, Na+ both in the absence and presence of Leu had similar 
effects, causing TMs 6b, 7a and the N-terminal segment of TM1a to close off the 
intracellular pathway 48,49. However, TM1a did not exhibit the extent of movement 
indicated by the inward-facing crystal structure, and TM5 did not move as predicted by 
the structure. The authors found that the inward-closed structure underestimates the 
extent of closing of TMs 1a and 6b, and that there were also inconsistencies between the 
crystal structures and DEER findings in the movements of TMs 2 and 7.  
The authors demonstrated that these discrepancies resulted from crystallographic 
conditions 49. Use of the same detergent (OG rather than DDM or proteoliposomes) 
produced the same DEER distance distributions as those predicted from the crystal 
structures, consistent with the assertion that OG binds to the S2 substrate site and 
produces an inhibited outward-open conformation. The authors also showed that the 
intracellular gate mutation that was used to obtain the inward-facing crystal structure led 
to a large movement of TM1a towards the membrane, as well as a movement of TM5 
consistent with the crystal structure.  The finding that mutants favor a state that is not 
observed in the wild-type transporter demonstrates the limitations of deriving inferences 
about the conformational states of the transport cycle from crystal structures of mutated 
and antibody-bound proteins.  
Crystal structures provide static snapshots from which the conformational changes of 
the transport cycle can only be inferred. EPR studies provide general information about 
mobility and dynamics, but cannot examine the kinetics of transitions between specific 
conformational states. A detailed understanding of the transport mechanism requires a 
description of the sequence and timing of transitions between specific conformations, and 
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their modulation by substrate and ions or inhibitors, as well as the rate-limiting steps, 
which are the most effective targets of modulation. Such a description requires 
techniques that probe conformational dynamics in transporters.  
 
1.4  Single-molecule FRET imaging to study the transport dynamics of LeuT 
 
 Single-molecule fluorescence resonance energy transfer (smFRET) is a technique 
suitable for examining conformational changes in proteins, as it is a “spectroscopic 
molecular ruler” sensitive to distances on the nanometer scale 50,51. In FRET studies, 
donor and acceptor fluorophores are attached to specific sites on mobile domains of the 
protein (Figure 1.5). The donor fluorophore is directly excited and transfers a fraction of 
the excitation energy by FRET to nearby acceptor fluorophores in a distance-dependent 
manner according to the following equation:  
EFRET = 1/(1 + (R/R0)6) 
where E is the efficiency of the energy transfer, R is the distance between the 
fluorophores, and R0 is the distance at which E = 0.5.  
 The value of R0 depends on the fluorophore pair used, and is related to the degree of 
overlap of the donor emission and acceptor absorbance spectra, among other factors: 
Figure 1.5 Single-molecule FRET imaging of LeuT. (a) LeuT is site-specifically labeled 
with donor and acceptor fluorophores. (b) FRET is distance-dependent on a nanometer scale. 
(c) Individual smFRET traces reveal transitions between specific conformational states.  
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R0 = 0.221 (κ2 * η-4 * θD * JDA)1/6 52 
where κ2 is the orientation factor, n is the refractive index of the medium, θD is the donor 
quantum yield, and JDA is the overlap integral of the donor and acceptor spectra (see 
Chapter 2 for calculations of these parameters). For example, R0 for the commonly used 
fluorophores Cy3 and Cy5 is ~58 Å. Thus, a distance change of ~8.5 Å leads to a FRET 
change of ~0.2, making this technique sensitive to conformational changes on the scale of 
those observed in the LeuT crystal structures and EPR studies.  
 FRET measurements performed in bulk are insensitive to events that occur 
asynchronously in a population of molecules.  However, FRET performed at the level of 
single molecules detects transitions between specific conformational states, thereby 
revealing the sequence and timing of events. Thus, due to its strong distance-dependence 
on the length scale of biological molecules and its sensitivity to stochastic events on a 
millisecond time scale, smFRET is a valuable tool for probing both structural and 
dynamic characteristics of transporters.  
 In collaboration, the Javitch and Blanchard groups previously developed smFRET 
methods to measure conformational fluctuations of LeuT 3,6, including the detection of 
transiently populated intermediate states, which may be masked by ensemble averaging 
in bulk measurements or suppressed under crystallographic conditions. Fluorophore-
labeled LeuT molecules were immobilized on a microscope slide at a low non-
overlapping density using a His-tag interaction. The donor fluorophores were excited, 
and the fluorescence signal was acquired from both the donor and acceptor fluorophores 
to measure FRET. To achieve high signal-to-noise ratio, total internal reflection (TIRF) 
imaging was used to reduce background fluorescence by exciting only the fluorophores 
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immobilized near the surface 53. Electron-multiplying charge-coupled device (EMCCD) 
cameras were used to achieve a time resolution on the order of milliseconds 53.  
The Javitch and Blanchard groups labeled sites at the intracellular and extracellular 
face of LeuT that exhibit changes in distance between the inward-facing and outward-
facing crystal structures, and demonstrated that smFRET at these labeling sites reports on 
conformational changes relevant to transport. At the intracellular face, they showed that 
movement of the N-terminal segment is associated with intracellular gating, and is 
regulated by substrate and inhibitor binding, as well as by mutations of the intracellular 
gating network 3,6 (Figure 1.6).  
At the extracellular face, where the distance changes between open and closed states 
are smaller, distinguishing different FRET states in the wild-type transporter and 
quantifying the dynamics posed a greater technical challenge. However, they 
demonstrated that the conformation of TM6a is affected by mutations of the intracellular 
gating network, suggesting that labeling sites at this region reported on FRET states 
corresponding to closed and open conformations of the extracellular face 6 (Figure 1.6). 
These results also suggested that this region is allosterically connected to the intracellular 
face, consistent with the alternating access model, and may be associated with 
extracellular gating.  
To date, no studies have examined the relationship between the dynamics of the 
extracellular and intracellular faces of LeuT under the same conditions in order to 
elucidate the mechanism by which binding of ligands to the extracellular face is 
translated into conformational changes at the intracellular face. An understanding of the 
transport cycle requires examination of the dynamics at the extracellular face, from which 
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endogenous ligands and modulatory drugs enter, as well as the intracellular face, from 
which substrate and Na+ are released. In this dissertation, I describe advances made in 
smFRET methodologies to enable imaging the conformational dynamics at the 
extracellular face of LeuT for the first time, in order to characterize the relationship to 
dynamics at the intracellular face under the same ligand conditions. In addition, I have 
sufficiently resolved the FRET states at the intracellular face to enable the identification 
and characterization of an intermediate state that is associated with transport activity. 
These studies provide insight into the manner in which ligand binding coordinates the 









living cells.  
  
Figure 1.6 smFRET imaging of LeuT reports on conformational states at 
both faces. (a) Movement of the N-terminal segment of TM1a is associated 
with intracellular gating (b) Intracellular gating dynamics are increased in the 
presence of Na+ and the substrate Ala. (c) The R5A intracellular gate mutation 
shifted the FRET distributions at the intracellular (H7C/R86C) and 
extracellular (K239C/H480C) face. Figure adapted from 6.  
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2. MATERIALS AND METHODS 
 
2.1 Sample Preparation 
 
2.1.1 DNA manipulations, protein expression and purification.  
DNA manipulations. Constructed pQO18 expression plasmids containing the gene for 
LeuT with an N-terminal His(10)-tag and either H7C/R86C, K239C/H480C or 
A309C/H480C double-cysteine mutations were available in the Javitch lab (LeuT lacks 
native cysteines). To create the L400S, F253A, N27A, and T354A mutants (Chapter 6), 
single amino-acid mutations were introduced to either H7C/R86C or K239C/H480C 
LeuT using a QuickChange PCR site-directed mutagenesis kit (Stratagene) following the 
recommended protocol. Primers for site-directed mutagenesis were synthesized by 
Invitrogen.  
The template DNA in the PCR product was digested with 1 uL of Dpn1 restriction 
enzyme by incubation at 37 °C for 1 hour. 1 uL of the product was transformed into 50 
uL of E. coli DH5-α cells (Invitrogen). For the transformation reaction, cells and DNA 
were incubated on ice for 30 min, heat pulsed for 45 s at 42 °C, and returned to ice for 2 
min. The transformed cells were incubated in 500 uL of SOC media for 1 hr while 
rotating, then cultured in LB agar plates supplemented with 100 ug/mL ampicillin. Three 
colonies were picked per reaction and grown in 5 mL lysogeny broth (LB) culture with 
100 ug/mL ampicillin O/N while rotating.  DNA was extracted from the cells by 
MiniPrep (Qiagen) following the recommended protocol. The resulting plasmids were 
verified by DNA sequencing (Macrogen) using the T7 promoter site as a priming site.  
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Protein expression. 1 uL of plasmid DNA containing the desired mutation was 
transformed into 50 uL of E. coli C41 (DE3) cells (Lucigen). Cells from a single colony 
were incubated in Terrific Broth (TB) (Novagen) with glycerol (0.4% v/v) supplemented 
with 100 ug/mL ampicillin, while shaking at 225 rpm.  Cells were grown to OD600 = 0.5 
and cooled for 1hr. Expression of LeuT was induced with 0.15 mM IPTG for 16 hrs at 20 
°C.  
 
Membrane purification. Cells were harvested at 3400 x g for 15 min, resuspended in 
lysis buffer to ~45 g per 200 mL (0.1 M KPi (pH 7.5), 5 mM MgCl2), and homogenized. 
Resuspended cells were lysed with an EmulsiFlex-C5 (Avestin) at ~15,000 psi for 3 
passages at 4 °C. The lysate was centrifuged at 10,000 x g for 20 min in a Beckman JA-
20 rotor to remove unbroken cells and cell debris, and the supernatant was saved. To 
remove bound sodium and leucine, three membrane washes were performed by 
centrifuging at 125,000 x g for 1 hr in a Beckman Ti-45 rotor to pellet the membranes, 
and resuspending the pellet in membrane wash buffer (50 mM Tris/Mes (pH 7.5)). After 
the final wash, the membrane pellets were frozen with liquid N2 and stored at -80 °C. 
 
Protein purification. Frozen membrane pellets were resuspended in solubilization buffer 
at 10 mL per g membranes (50 mM Tris/Mes (pH 7.5), 20% glycerol, 150 mM NaCl, 1 
mM TCEP) and solubilized for 1 hr in 1.5% dodecyl-maltoside (DDM) (>99%, Anatrace 
D310) while rotating at 4 °C. The solution was centrifuged at 260,000 x g for 30 min in a 
TLA 100.3 rotor to remove vesicles and insoluble material.  
LeuT was purified by His-tag interaction by batch binding the supernatant for 1 hr 
at 4 °C to 0.4 mL Ni2+ Sepharose 6 FastFlow resin (GE Healthcare) pre-equilibrated with 
	  
	   17	  
wash buffer (50 mM Tris/Mes (pH 7.5), 20% glycerol, 150 mM NaCl, 1 mM TCEP, 
0.05% DDM), with 10 mM imidazole to reduce nonspecific binding. The column was 
washed with 10 column volumes (CV) of wash buffer with 30 mM imidazole to remove 
nonspecifically bound protein. Pure LeuT was eluted with 300 mM imidazole in 0.5 CV 
fractions. Protein content was qualitatively estimated with the Bradford assay 54, and 
fractions with significant protein content were pooled. The protein concentration was 
then quantified with the Bradford assay, and purity was assessed by SDS-PAGE.  
 
2.1.2 Site-specific labeling 
  To label 
double-cysteine LeuT 
mutants, the sample 
was exchanged into 
labeling buffer (40 
mM Mes (pH 6.0), 
400 mM NaCl, 0.05% 
DDM, with 200 uM 
lysine to reduce 
nonspecific labeling) 
using a spin column 
with 30 kDa filter. The 
solution was 
concentrated 2-fold to 0.1% DDM, the maximum level that does not alter function by 
binding to the S2 site 43. Maleimide-activated dyes (Cy3, Cy5, etc.) were resuspended in 
Figure 2.1 Site-specific fluorophore labeling and purification of 
labeled LeuT. (a) SDS-PAGE gel of wild-type (left lane) and 
K239C/H480C (right lane) labeling reactions visualized by 
Coomassie stain (left) and by UV excitation with Cy3 detection at 
535 nm (middle) and Cy5 detection at 670 nm (right). (b) 
Chromatogram of size-exclusion purification of Cy3/Cy5-labeled 
LeuT, with absorbance shown for protein at 280 nm (blue), Cy3 at 
550 nm (green), and Cy5 at 650 nm (red). LeuT elutes as a dimer 
(~60 mL), which is discarded, and as a monomer (~67 mL).  
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dry DMSO to 10 mM, mixed in a 1:1 ratio and added to the sample for a final 
concentration of 200 uM. Where indicated, laboratory-made Cy3 and Cy5 “self-healing” 
dyes covalently linked to cyclooctatetraene (COT) were used for enhanced photostability 
55. The reaction was incubated for 1 hr at 4 °C while rotating. Unreacted dye was 
quenched by adding 30 mM BME and incubating for 10 min at 4 °C while rotating. 
Labeling was site-specific for introduced cysteines (Figure 2.1a).  
Dye-labeled LeuT was purified by size exclusion chromatography (SEC) using a 
Superdex 200 HiLoad 16/60 gel filtration column and a fast protein liquid 
chromatography (FPLC) AKTA system. The column was first equilibrated with FPLC 
buffer (50 mM Tris/Mes (pH 7.5), 150 mM NaCl, 5 mM BME, 0.02% DDM). Prior to 
injection, the sample was centrifuged at 18,000 x g for 10 min to remove aggregated 
material. LeuT eluted at ~65-70 mL (Figure 2.1b). The eluent was raised to 20% 
glycerol and concentrated 5-fold to 0.1% DDM using a spin column with 30 kDa filter. 
Typical yields were ~150 ug per 4 L of original culture. The sample was frozen in liquid 
N2 in 5uL aliquots and stored at -80 °C.  
To obtain more concentrated dye-labeled samples for transport assays, LeuT was 
labeled on the Ni2+ column and was not further purified by SEC. The protocol was as 
follows. After batch binding, the column was washed with 10 CVs of labeling buffer, the 
resin was transferred to an eppendorf tube and spun down, and the supernatant was 
removed. The dye mixture at 200uM in labeling buffer was added to the resin, and the 
mixture was rotated for 1 hr at 4 °C. The column was then washed with 10 CVs of wash 
buffer and eluted with 300 mM imidazole in 0.5 CV fractions and the protein 
concentration was measured by Bradford assay as described above. Protein produced by 
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both labeling and purification protocols performed similarly in transport assays and 
smFRET, but the more concentrated samples increased the reliability of transport assay 
measurements.  
 
2.2 Transport Activity Assay 
 
2.2.1 Preparation of proteoliposomes  
Liposome preparation. E. coli polar lipid extract (100600C, Avanti) and egg 
phosphotidylcholine (131601C, Avanti) in chloroform solution were mixed in a 3:1 ratio 
(w/w) in a 250 mL glass beaker using glass pipettes to transfer the lipids. The chloroform 
was evaporated under argon flow in a fume hood while stirring with a Teflon stir bar. 
When all chloroform appeared to be removed, argon flow was continued for an additional 
hour to remove any residual chloroform. The lipid was resuspended to 20 mg/mL in 
degassed, argon-saturated K6 buffer (0.1 M KPi (pH 6.0), 5 mM BME) and solubilized 
with 1.5% octylglucoside (OG) (O311, Anatrace) by stirring for 2 hrs at room 
temperature. To remove detergent, the solution was dialyzed against 1 L of K6 buffer 
with three buffer changes. The sample was distributed in 10 mg aliquots, frozen in liquid 
N2 and stored at -80 °C.  
 
Protein reconstitution into liposomes. To create uniform liposomes of the desired 
diameter, the sample was extruded using a mini-extruder (Avanti) with a 400 nm 
polycarbonate filter (610007, Avanti), then diluted to 5 mg/mL. The liposomes were 
destabilized with Triton X-100 at a concentration corresponding to the onset of 
solubilization (usually ~0.17% w/v). This concentration was determined for each 
liposome preparation by measuring the light scattering of liposomes at 500 nm as a 
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function of Triton concentration in order to 
detect liposome swelling induced by Triton 
(Figure 2.2). A detergent concentration was 
identified that destabilized the liposomes 
without fully solubilizing them.  
After destabilization, LeuT was added 
to liposomes at a 1:150 w/w ratio and 
incubated for 15 min at room temperature 
while rotating. To create “empty” liposomes 
for control samples, buffer was added without protein. Detergent was removed using 
Biobeads SM-2 (Bio-Rad), which were prepared by washing extensively with MeOH, 
ddH2O, and then K6 buffer. The detergent was slowly removed with Biobeads in 3 
stages: 80 mg/mL for 1 hr, an additional 80 mg/mL for 1 hr, and 160 mg/mL overnight at 
4 °C. To ensure that all detergent was removed, an additional 160 mg/mL was incubated 
for 1 hr at room temperature. Liposomes were separated from Biobeads using a thin glass 
pipet and pelleted at ~70,000 x g for 45 min in a TLA-100.3 rotor with inserts for 1.5mL 
microcentrifuge tubes. The liposome pellet was resuspended in K6 buffer to 30 mg/mL 
and subjected to three freeze-thaw cycles with liquid N2 to fully exchange the internal 
solution (which may contain sodium).  
 
Measuring reconstitution efficiency. The concentration of protein in the proteoliposomes 
was measured using the lipid-modified amidoblack assay with 0.45 um filters 
(Millipore)56. A calibration curve was obtained using known amounts of bovine serum 
albumin (BSA). Multiple dilutions of the proteoliposome sample were measured (with 
Figure 2.2 Swelling of liposomes 
measured by light scattering at 500 nm 
as a function of Triton concentration. 
The onset of solubilization is at 0.17% 
Triton.	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10-20 ug of protein per 2mL ddH2O), and the average value was used. Typical 
reconstitution efficiencies were ~25-40%. 
 
2.2.2 Transport assays  
5 mg of proteoliposomes was thawed and extruded with a 400 nm polycarbonate 
filter to a final volume of 300uL. Proteoliposomes were diluted 50-fold into Na8 buffer 
(50 mM KPi (pH 8.0), 50 mM NaCl) with 1.1 uM 3H-alanine (40-50 Ci/mmol, Movarek), 
briefly vortexed and incubated at room temperature. In control experiments, empty 
(protein-free) liposomes were used. At each time point, a 200uL aliquot was removed 
from the reaction and diluted 10-fold into ice-cold quench buffer (100 mM KPi (pH 6.0), 
100 mM LiCl), followed by immediate filtration over nitrocellulose filters (0.22um, 
Millipore). Filters were washed twice with 2 mL of ice-cold quench buffer, briefly dried 
on a Kimwipe, dissolved in 5 mL of scintillation cocktail (RPI) in scintillation vials for 
~24 hrs, and assayed for radioactivity using a Trilux beta counter (Perkin Elmer Life 
Sciences). Turnover rates were estimated by normalizing to the concentration of protein 
in the proteoliposomes, determined using the lipid-modified amidoblack assay as 
described above. Error bars were calculated as the standard error across at least three 
independent experiments. Environmental Health and Safety radiation safety courses were 
completed and monthly radiation wipe tests were performed.   
 
2.3 Binding Activity Assay 
Binding of 3H-leucine or 3H-alanine (146 Ci/mmol and 49.4 Ci/mmol, 
respectively, both from Moravek) was measured with the scintillation proximity assay 
(SPA) as previously described for LeuT3, using 25 ng of protein per assay in buffer 
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composed of 150 mM Tris/Mes (pH 7.5), 50 mM NaCl, 1 mM TCEP, and 0.1% DDM. 
Protein was incubated with increasing concentrations of radioligand and measured in the 
SPA counts per min (cpm) mode of the Wallac 1450 MicroBeta counter (Perkin Elmer). 
Standard curves of known radioligand concentrations were used to transform cpm into 
the amount of bound ligand. Experiments were performed with triplicate determination of 
all individual data points.  
 
2.4 Single molecule FRET imaging experiments 
2.4.1 Experimental set-up. All smFRET experiments were performed using a laboratory-
built prism-based total internal reflection fluorescence (TIRF) apparatus constructed 
around an Olympus TE2000 Eclipse inverted microscope body (Figure 2.3). 
Fluorophore-labeled biomolecules were immobilized on a glass slide and enclosed within 
a microfluidic chamber. Custom-designed quartz slides containing the imaging chambers 
were available in the Blanchard lab.  
Fluorophores were excited by an evanescent wave generated by TIR of light off 
the glass slide, which penetrated ~100 nm into the sample and exponentially decayed, 
exciting immobilized particles without generating significant background fluorescence. 
The excitation beam was directed at a quartz prism (PLBC-5.0-79.5-SS, Melles Griot) 
that was coupled to the slide with immersion oil (n=1.46, Cargille) and reflected off the 
slide at a shallow angle to generate TIR. The excitation beam was focused to ~100 um 
diameter at the sample, to avoid photobleaching fields outside the field-of-view (~100 x 
100 um) during acquisition.  
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A high-power, single-frequency diode laser, (Opus 532, 2W, LaserQuantum), was 
used to excite Cy3 fluorophores, with a narrow-band clean-up filter to remove other 
frequencies (532 nm MaxLine Laser Line filter, Semrock). Quarter waveplates were used 
to produce elliptically polarized light from the linearly polarized light. Fluorescence 
emission was collected by a 60X, 1.27 NA, water-immersion objective (Nikon) and 
spectrally split into two channels with a 640dclp dichroic mirror (Chroma) using a Dual-
Cam device (Photometrics). The images were projected onto separate electron 
multiplying charge-coupled device (EMCCD) cameras (Evolve 512, Photometrics). In 
most experiments, Cy3 and Cy5 fluorescence were the two channels. A 550dclp filter 
(Chroma) was used to remove scattered excitation light. Data were acquired in 
Metamorph software (Universal Imaging Corporation). If not otherwise specified, the 
Figure 2.3 Schematic representation of the smFRET TIRF microscope configuration. 
Excitation light travels from lasers (lower right) through quarter-waveplates, electronic 
shutters, clean-up filters, beam-combining dichroic mirrors (DC1 and 2), beam-shaping lenses, 
and a focusing lens (FL) to direct the beam through a prism to generate TIR. Fluorescence 
emission from the sample is collected through the objective. The surface immobilization of 
labeled LeuT molecules is depicted.   
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integration time for photons was 100ms. The signal was then amplified and digitized to 
convert the information into pixel format.  
The imaging chamber, which was passivated with a mixture of PEG and biotin-
PEG, was flushed with T50 buffer (10 mM Tris/acetate (pH 7.5), 50 mM KCl) and 
incubated for 5 min with a mixture of 0.8 uM streptavidin (Invitrogen), 1 uM BSA, 1 uM 
25nt DNA, and 0.1% (v/v) glycerol in T50 buffer. Then it was washed with T50 and 
incubated with 8 nM biotin-Tris-NTA-Ni2+ (available in the Blanchard laboratory) in T50 
buffer, and washed with T50.  Then the chamber was washed with imaging buffer 
containing 50 mM Tris/Mes (pH 7.0 unless otherwise indicated), 10% glycerol, 0.02% 
(w/v) DDM, 200 mM salt (KCl or NaCl, as specified), 1 mM BME, 2 mM COT (Sigma), 
and blocking agent (0.1 uM BSA, 0.1 uM DNA, 0.01% glycerol in T50 buffer), 
supplemented with an enzymatic oxygen scavenging system (0.1% glucose, 1 unit/mL 
glucose oxidase (Sigma), 8 units/mL catalase (Sigma)). Before use, catalase was purified 
using SEC, on a Sephadex column. All buffers were degassed and argon-saturated 
immediately before imaging to minimize oxygen. Dye-labeled LeuT samples at ~4 nM in 
imaging buffer were surface-immobilized by His-tag interaction with biotin-Tris-NTA-
Ni2+. The specificity of the His-tag immobilization of LeuT has been previously 
demonstrated 6.  
 
2.4.2 Data Analysis 
Single-molecule detection and trace selection. For each acquired movie, fluorophore-
labeled particles were identified as local intensity maxima, with threshold criteria of 8 
standard deviations (SDs) above background noise. Any molecules closer than 3 average 
point spread function (PSF) SDs apart were rejected to avoid signal contamination 
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between neighboring particles. Intensity maxima in the donor and acceptor channels 
corresponding to the same particle were associated using the iterative closest point (ICP) 
algorithm 57. To generate fluorescence-time traces from each particle, the highest 
intensity pixels in the region around the maximum were summed (a region 5 times the 
average PSF SD).  
In order to interpret FRET efficiency as a measure of the distance between donor 
and acceptor fluorophores, several corrections are made to the FRET signal. The average 
background intensity observed after donor photobleaching was subtracted from each 
donor and acceptor trace. The crosstalk or spectral bleed-through of the donor to the 
acceptor channel was estimated from the residual acceptor intensity after acceptor 
photobleaching and was subtracted from the acceptor traces. The gamma or relative 
brightness of the two fluorophores was estimated from the changes in donor and acceptor 
intensity upon acceptor photobleaching, and this value was used to scale the acceptor 
intensity to the same brightness as the donor.  
FRET traces were calculated according to the equation: EFRET = IA/(IA + ID), 
where IA and ID are the acceptor and donor fluorescence intensity at each time-point. 
FRET was set to zero in intervals where total intensity (IA + ID) was less than 6 SDs of 
background noise, corresponding to donor blinking events or photobleaching.  
Traces were automatically selected for analysis if they met the following criteria: 
number of donor blinks < 3, SNR-background > 8, SNR-signal > mean for the dataset, 
donor-acceptor intensity correlation < 0.5, FRET lifetime > 375 frames (37.5 s), at least 
one frame with FRET > 0.3, and exactly one photobleaching event. SNR determines the 
capability to distinguish distinct FRET states in the traces. SNR-background is defined as 
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the mean total fluorescence intensity (MTI) divided by the SD of background intensity 
immediately after donor photobleaching. SNR-signal is defined as the MTI divided by 
the SD of the total intensity before donor photobleaching, ignoring regions where the 
donor is dark. To ensure that each trace contained the signal from exactly one donor and 
one acceptor, the number of donor fluorophores was determined by automatically 
counting the number of photobleaching steps (rapid irreversible drops in total intensity).  
These criteria were effective in removing artifacts and spurious noise without 
introducing significant bias, determined by comparing the population behavior of the 
selected subset of data to the full dataset. For visualization purposes only, when 
constructing FRET population histograms the FRET traces were filtered using a non-
linear forward-backward filter that reduces noise while minimizing distortions58,59. 
Unfiltered data were used for all fitting and analyses. For unfiltered FRET population 
histograms, see Appendix.  
 
FRET data idealization and model selection. To quantify the FRET state populations 
and their kinetic properties, each data point along the FRET trajectory was assigned to a 
state of a model. Models were created with three nonzero FRET states with mean 
amplitudes and standard deviations estimated by fitting FRET population histograms to a 
sum of three Gaussian functions. In addition, zero FRET states were created 
corresponding to reversible and irreversible transitions to dark states (fluorophore 
blinking and photobleaching, respectively). Initial model rates were set to 0.01 s-1, as 
estimated from visual inspection of FRET traces. A segmental k-means (SKM) algorithm 
optimized the model rates for each trace during fitting and assigned the state of the 
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system at each time-point, creating an idealization. This procedure was implemented 
using QuB software (http://www.qub.buffalo.edu/).  
Traces were automatically removed from subsequent analysis if the mean FRET 
values assigned to any two states were less than 0.07 apart. Blinking events were 
removed from the idealization to prevent underestimation of the dwelltimes in nonzero 
FRET states. However, residual blinking events that were mis-assigned to nonzero FRET 
states might contribute to underestimation of the dwelltimes. Photobleaching, which 
occurred on average at ~ 60 s, also leads to underestimation of dwelltimes, although this 
artifact was reduced by selecting only long-lived traces for analysis (> 375 frames or 37.5 
s). In addition, dwelltimes near the sampling interval (100 ms) sometimes cause 
transitions to be missed, leading to overestimation of dwelltimes.  
State occupancy curves were fit using the Hill equation: P = Cn/(Kdn + Cn), where 
C is the concentration of the titrant, Kd is the dissociation constant and n is the Hill 
coefficient. The fits were obtained using OriginLab software. Error bars were calculated 
as the standard error across at least three independent experiments on separate days. 
Average dwell times in each FRET state were estimated using a maximum likelihood 
algorithm (MIL) 60,61 in QuB, which combined the dwelltime information from all the 
traces to iteratively optimize the model rates and generate a single optimal model. The 
accuracy and robustness of the analysis procedures was verified using simulations of 
FRET traces, varying the noise (FRET value standard deviation) and rate constants.  
 
Estimation of distances from FRET values. To aid in assigning FRET states to specific 
conformations by comparison with crystal structures and molecular dynamics 
simulations, inter-dye distances were calculated from FRET values. We estimate the 
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upper limit of the error in the distances to be ± 5 Å 6. FRET values were first corrected 
for spectral bleed-through that occurs due to imperfect separation of the donor and 
acceptor fluorescence by the dichroic mirrors. This correction was applied: 
E = (Eobs  – α)/(1 – β – α) 
where α = 0.075 and β = 0.155 were estimated from the fluorescence emission spectra of 
Cy3 and Cy5 and the transmission spectra of optical components in the light path 6.  
Corrected FRET values (E) were then used to calculate the average distance 
between Cy3 and Cy5 (R) using the following equation:  
R = R0 ((1-E/)/E)1/6 
where R0 is the distance at which 50% of the donor excitation energy is transferred to the 
acceptor. R0 = 58.4 Å was estimated for Cy3/Cy5-labeled LeuT according to the 
equation: R0 = 0.221 (κ2 * η-4 * θD * JDA)1/6 52. The orientation factor κ2 was assumed to be 
2/3 given isotropic rotation of fluorophores on the millisecond timescale, as Cy3 
anisotropy was previously measured at multiple sites of labeling in LeuT and was 
consistent with substantial randomization of orientation on the imaging time scale (40-
160ms) 6. The refractive index η of the experimental solution was estimated to be 1.4 6. 
The spectral overlap integral J was previously calculated to be 8.5 x 10 ^ -13 M-1cm3 6 
using the normalized fluorescence emission and absorption spectra of single-cysteine-
labeled Cy3-LeuT and Cy5-LeuT, respectively.  
The donor quantum yield θD of Cy3-LeuT was previously estimated to be 0.23 6 
using the comparative method with Rhodamine 101 (Sigma) in ethanol as a standard (θ = 
1.0) 62. Our previous smFRET studies of LeuT indicated that changes in donor quantum 
yield do not account for FRET changes, as the presence of ligands that induce FRET 
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changes did not affect the spectral shift and intensity of Cy3-LeuT 6. In addition, the 
fluorescence lifetimes of Cy3-LeuT and Cy5-LeuT were also independent of ligand 
concentration 6.  
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3. OPTIMIZATIONS IN METHODOLOGY FOR SMFRET OF LEUT 
 In this dissertation, I have optimized the methodology of our smFRET studies for 
LeuT in order to obtain data with greater accuracy and higher signal-to-noise ratio (SNR), 
allowing imaging of the dynamics at the extracellular face for the first time, as well as 
sufficiently resolving the intracellular FRET states to enable the identification and 
characterization of a previously undetected intermediate state.  
 
3.1 Optimization of smFRET imaging buffers 
3.1.1 Purification of catalase 
 Signal quality in smFRET studies using organic fluorophores is limited by 
fluorophore blinking (reversible transitions to dark states) and photobleaching 
(irreversible transitions to dark states). In our automated smFRET analysis, blinking is 
often falsely detected as transitions between conformational states, while photobleaching 
Figure 3.1 Purification of catalase reveals the effects of Na+ and substrate in the absence 
of contaminants. (a, c) In the presence of unpurified CAT, the EC50 for the effect of Na+ on 
the smFRET distribution was ~ 10 mM, while (b, d) in the presence of purified CAT it was ~ 
100 mM. Lines in (c, d) are fits to Hill equation with n = 2. (e) Unpurified CAT prevents 3H-
Ala uptake, while purified CAT does not affect transport activity.  
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reduces the amount of data that can be collected. Molecular oxygen, which is present in 
buffers at ambient conditions at ~0.5 mM, induces fluorophore photobleaching by 
interacting with the excited states of fluorophores or by producing free radicals in 
solution that interact with fluorophores 63. Therefore, enzymatic oxygen scavenging 
systems are widely used to remove oxygen from buffers. A mixture of glucose with 
glucose oxidase and catalase (GOD-CAT) can reduce the oxygen concentration to a few 
micromolar, which can increase the photobleaching lifetime by several orders of 
magnitude 64.  
Our previous smFRET studies of LeuT have used CAT purified from bovine liver 
(Sigma) in a GOD-CAT system. However, as we were concerned about possible 
contaminants in the reagent, we implemented an additional purification step of size 
exclusion chromatography. I compared the effects of Na+ on the conformational states at 
the intracellular face of LeuT in the presence of CAT before and after the additional 
purification step, and found that the use of purified CAT increased the EC50 of the effect 
of Na+ on the FRET distribution ~10-fold (Figure 3.1).  This suggested that the impure 
CAT reagent might contain amino acids that bind to LeuT and increase its affinity for 
Na+, as the affinity of LeuT for Na+ is expected to increase in the presence of substrate 21. 
Supporting this hypothesis, 3H-Ala uptake was eliminated in the presence of unpurified 
CAT, but was unaffected by purified CAT, suggesting that the contaminant competes 
with Ala (Figure 3.1). Furthermore, we found that a leucine, isoleucine, valine-binding 
protein (LIV-BP) smFRET sensor developed by the Blanchard laboratory exhibited a 
Leu-induced conformational change in the presence of purified CAT but not unpurified 
CAT, suggesting that the contaminant in unpurified CAT bound to LIV-BP and 
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prevented binding of Leu (data not shown). The use of purified CAT in our smFRET 
studies enabled us to determine the unique effects of Na+ alone more accurately than in 
our previous studies, leading to novel predictions that were subsequently supported by 
functional data (Chapter 4).  
 
3.1.2 Optimization of beta-mercaptoethanol (BME) concentration 
 As a fluorophore cycles between the singlet excited state and the ground state, it 
emits fluorescence photons. However, approximately once every 1,000 excitations, it 
visits the triplet state, which does not emit photons, producing blinking 63. The triplet 
state is also often an intermediate on the pathway to photobleaching 63. The triplet state is 
quenched by molecular oxygen, returning the fluorophore to the ground state, but if 
oxygen is removed in order to increase the photobleaching lifetime (as described above), 
an alternative triplet state quencher (TSQ) is often used, such as BME 63. Dark states also 
occur when the fluorophore is oxidized or reduced, yielding a radical ion that does not 
absorb in the visible range, and as a reductant BME is a useful radical scavenger 63. 
However, Cy5 in the excited state reacts with thiols, and this reaction also produces dark 
states 65-67. Therefore, an optimal concentration of BME must be selected to balance the 
TSQ and radical scavenger effects with the effects of its reaction with Cy5.  
Our previous smFRET studies of LeuT have been performed at 5 mM BME, a 
concentration that was chosen to maximize fluorophore lifetimes. However, to quantify 
transitions between poorly separated FRET states at the extracellular face, as well as to 
better resolve the intracellular FRET states, it was necessary to reduce blinking to achieve 
higher SNR. I compared the photophysical properties of Cy3/Cy5-labeled LeuT at 
various concentrations of BME and determined that 1 mM BME provided the optimal 
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balance of lifetime enhancement and blinking prevention for LeuT studies (data not 
shown).  
As the deleterious effects of BME are more prominent at higher pH due to higher 
probability of forming adducts with Cy5 67, this optimization proved essential for 
conducting studies of the effect of pH on LeuT (Chapter 5). However, to study the 
effects of Na+ and substrates (Chapter 4), all experiments were performed at pH 7 rather 
than pH 7.5 as in our previous smFRET studies, in order to achieve optimal photophysics 
in the presence of BME, as the overall results obtained under both conditions were in 
close agreement.   
 
3.2 Use of self-healing fluorophores 
 In our previous smFRET studies, LeuT was labeled with Cy3 and Cy5 
fluorophores. The Blanchard laboratory has developed self-healing fluorphores 55 that are 
conjugated to TSQs such as cyclooctatetraene (COT) to increase the effectiveness of the 
TSQs and avoid the negative effects of TSQs in solution, such as limited solubility, 
toxicity to biological systems, and decreased membrane integrity 55. They have also 
added additional sulfate groups to reduce the hydrophobicity associated with COT, in 
order to prevent the fluorophores from interacting with the detergent micelles. I labeled 
LeuT with the self-healing fluorophores Cy3-4S-COT and Cy5-4S-COT, and 
demonstrated that these fluorophores increase the SNR compared to the parent 
fluorophores, under imaging conditions that yield similar FRET lifetimes (Figure 3.2, 
Figure 4.2), significantly improving our discrimination of distinct FRET states. The 
optimization of conditions for smFRET imaging of LeuT also represents an important 
step towards reaching an eventual goal of single-molecule imaging of membrane proteins 
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in living cells, in which labeling and high-SNR imaging of the extracellular face will be 
crucial.  
Figure 3.2 Optimization of buffer 
conditions and fluorophores enables 
detection of poorly separated FRET 
states at the extracellular face of LeuT. 
Representative extracellular smFRET 
traces under the (a) original smFRET 
conditions and (b) optimized conditions 
with purified CAT, lower BME 
concentration, and self-healing 
fluorophores. 	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4. IDENTIFICATION OF CONFORMATIONAL STATES ASSOCIATED WITH 
LIGAND BINDING AND TRANSPORT AT THE EXTRACELLULAR AND 
INTRACELLULAR FACES OF LEUT 
 
4.1 Introduction 
The NSS family of membrane transporters is responsible for regulating the 
spatiotemporal dimension of signaling through reuptake and recycling of 
neurotransmitters from the synaptic cleft. This family includes the transporters for 
serotonin, norepinephrine, and dopamine (SERT, NET, DAT,), which are targeted by 
antidepressants and psychostimulants such as amphetamines and cocaine 9,12. In addition, 
NSS for GABA (GAT) and glycine (GlyT) are promising targets for the treatment of 
epilepsy and anxiety disorders, or schizophrenia, respectively 13-15. These secondary 
active transporters couple the re-uptake of substrates and Na+ across the plasma 
membrane of presynaptic neurons, using the physiological Na+ gradient to facilitate the 
thermodynamically unfavorable accumulation of substrate inside the cell 8. Prokaryotic 
NSS homologs have proven to be highly valuable model systems 20, owing to their 
stability and ease of expression. The amino acid transporter LeuT has been crystallized in 
inward-facing, outward-facing, and substrate-bound occluded conformations that have 
been interpreted as states visited in the transport cycle, providing structural context for 
the investigation of NSS function 1,4.  
An alternating access mechanism has been proposed for NSS transporters, in 
which the Na+ and substrate-binding sites are alternately exposed to the extracellular and 
intracellular side of the membrane. However, little is known about the means by which 
binding and unbinding of ligands coordinates motions at the two faces. Different models 
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postulate either rigid-body movements of entire transmembrane helices (TMs) in a 
“rocking bundle” mechanism 46, or local movements of the intracellular versus 
extracellular segments of flexible TMs 1,68. We previously developed single-molecule 
fluorescence resonance energy transfer (smFRET) methods to measure conformational 
fluctuations of LeuT 3,6. In FRET studies, donor and acceptor fluorophores are attached to 
specific sites on mobile domains of the protein. The donor fluorophore is directly excited 
and transfers a fraction of the excitation energy by FRET to a nearby acceptor 
fluorophore in a distance-dependent manner. Thus, FRET is used as a “spectroscopic 
molecular ruler” to track the distance between different sites on the protein at each time-
point. FRET studies performed at the level of single molecules enable the detection of 
transiently populated intermediate states, which may be masked by ensemble averaging 
in bulk measurements or suppressed under crystallographic conditions.  
In LeuT, we previously labeled sites at the intracellular and extracellular face that 
exhibit changes in distance between the inward-facing and outward-facing crystal 
structures, and we demonstrated that smFRET at these labeling sites reports on 
conformational changes relevant to transport. At the intracellular face, we showed that 
movement of the N-terminal segment is associated with intracellular gating, and is 
regulated by substrate and inhibitor binding, as well as by mutations of the intracellular 
network 3,6. Movement of this region was confirmed by EPR studies, which also 
elucidated other conformational changes 49. At the extracellular face, where the distance 
changes between open and closed states are smaller and therefore the signal-to-noise ratio 
(SNR) is reduced, distinguishing different FRET states in the wild-type transporter and 
quantifying the dynamics posed a significant technical challenge 6. Nonetheless, our 
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results indicated that the conformation of TM6a is affected by mutations of the 
intracellular network 6, suggesting that this region, which we have previously shown 
participates in the binding of a second substrate molecule 21, is allosterically connected to 
the intracellular face, consistent with the alternating access model, and may be associated 
with extracellular gating.  
In the current study, we characterized the specific FRET states and 
conformational dynamics at the extracellular face of LeuT for the first time by using 
“self-healing” fluorophores, which have improved photophysical characteristics 
compared to the parent fluorophores 69, to overcome the lower SNR. To date, no studies 
have examined the relationship between the dynamics of the extracellular and 
intracellular faces of LeuT, which is essential to elucidating the mechanism by which 
binding of ligands to the extracellular face is translated into conformational changes at 
the intracellular face. Thus, it remains uncertain whether the two faces move as a rigid 
body, with opposite (open versus closed) conformations and identical ligand-induced 
dynamics, as would be predicted by the “rocking bundle” model 46, or whether the two 
faces can move flexibly and independently 1.  
 
4.2 Results 
4.2.1. Identification of intermediate conformations at both faces of LeuT 
Previously, our smFRET measurements between the N-terminal segment and IL2 
at the intracellular face of LeuT (H7C/R86C, Figure 4.1a) demonstrated two distinct 
FRET states (~0.73 and ~0.49), with spontaneous dynamics on a timescale of 10s of 
seconds in the absence of ligands 3.  With self-healing fluorophores 55 and other 
optimizations (see Chapter 3), SNR was improved significantly without altering 
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transporter function (Figure 4.2). Due to these advances, an intermediate FRET state 
(~0.56) has become reliably discernible (Figure 4.1b, c).  
We calculated inter-dye distances from FRET values (see Methods), and we 
compared the changes in distances measured by FRET to those predicted from the crystal 
structures (measuring from the Cβ of residues in the structures to more closely 
approximate the dye locations). The distance change between the high and low-FRET 
states (from 0.73 to 0.49 FRET, corresponding to 14 Å) was comparable to the distance 
change between the inward-closed/outward-open and inward-open/outward-closed crystal 
structures of LeuT (17 Å, measured between residues 11 and 86, as residue 7 is not 
resolved in the inward-open crystal structure) 1 (Figure 4.3a, c, Table 4.1).  
Figure 4.1 Intracellular and extracellular labeling of LeuT reveals intermediate FRET 
states at each face. (a) H7C/R86C or (b) K239C/H480C-LeuT was labeled with Cy3 and Cy5 
or self-healing Cy3 and Cy5 fluorophores (stars). (c, d) FRET traces (>200 per condition) 
were collected with 100-ms time resolution. Representative donor intensity (green), acceptor 
intensity (red), and smFRET (blue) traces from the intracellular and extracellular face. 
Predicted state sequences (idealizations) are shown in red overlay of the smFRET traces. (e, f) 
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The mid-FRET state therefore likely corresponds to an intermediate, presumably 
inward-facing, conformation (10 Å from the closed state) that has not yet been observed 
by crystallography in LeuT but might be similar to an inward-open LeuT simulation (~7 
Å from the closed state) 6 It is unclear from distances alone whether the substrate site is 
occluded or solvent-exposed in this intermediate state. 
In contrast to the intracellular face, comparatively little is known about 
conformational dynamics at the extracellular face. Previous smFRET measurements 
between TM6a and TM12 (K239C/H480C, Figure 4.1b) lacked sufficient resolution to 
identify specific states 6. With the improved SNR, three distinct extracellular FRET states 
have become resolvable (Figure 4.1d, f).  
Figure 4.2 Self-healing fluorophores have high SNR and do not alter function. (a) 
Fluorophores were conjugated to the triplet state quencher cyclooctatetraene. (b) Self-healing 
fluorophores have greater signal-to-noise ratio than parent dyes under conditions yielding 
similar FRET lifetimes. Histograms were fit to Gaussian distributions centered at 16 for parent 
dyes and 28 for self-healing dyes. (c-f) A similar effect of Na+ on smFRET was observed in 
H7C/R86C-LeuT labeled with parent Cy3 and Cy5 fluorophores or self-healing fluorophores 
under the same conditions. Lines in (c, d) are fits to Hill equation with n = 2. (g) H7C/R86C 
or K239C/H480C-LeuT labeled with self-healing fluorophores demonstrated similar affinity 
and stoichiometry of 3H-Leu binding as wild-type unlabeled LeuT.  
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The distance changes between the low- and mid-FRET states (from 0.56 to 0.64 
FRET, corresponding to 4 Å), and between the mid- and high-FRET states (from 0.64 to 
0.72, corresponding to 5 Å) were comparable to distance changes between these labeling 
sites in the outward-open/inward-closed 1 and outward-facing occluded/inward-closed 4 
crystal structures (3 Å), and between the outward-facing occluded/inward-closed 4 and 
outward-closed/inward-open 1 crystal structures (6  Å), respectively (Figure 4.3b, d, 
Table 4.1). Although the mid-FRET state corresponded to a distance similar to that 
observed in the outward-facing occluded crystal structure, it is unclear from distances 
alone whether the substrate site is occluded or solvent-exposed in this state. SmFRET 
measurements between additional extracellular labeling sites at EL4 and TM12 
Figure 4.3 FRET state assignments. Overlay of 3TT1 (green), 2A65 (magenta), 3TT3 (cyan) 
crystal structures, and inward-open simulation (wheat), demonstrating distances between 
intracellular (a) and extracellular (b) labeling sites and corresponding FRET states in 
representative intracellular (c) and extracellular (d) traces. (e, g) Conformationally-selective 
nanobody stabilized the intracellular low-FRET state and (f, h) extracellular high-FRET state, 
supporting FRET state assignments to inward-open and outward-closed conformations.  
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(A309C/H480C, Figure 4.6a) also revealed three FRET states that roughly corresponded 




To better understand the physical nature of the FRET states, we used a 
conformationally-selective nanobody targeted to LeuT: functional studies showed that 
nanobody binding favors a state that no longer binds Leu, which we have inferred to 
represent an inward-open conformation 70. As hypothesized, at the intracellular face the 
nanobody strongly stabilized the low-FRET state, supporting the assignment of the low-
FRET state to an inward-open conformation (Figure 4.3e, g). The FRET value of this 
low-FRET state was similar to that observed in the apo transporter, suggesting that the 
nanobody stabilizes a similar open conformation. At the extracellular face, the nanobody 
stabilized the high-FRET state (Figure 4.3f, h). This observation provided additional 
evidence that the extracellular high-FRET state is fully closed on the outside and most 
likely associated with an inward-facing conformation. We previously demonstrated a 
similar effect of the R5A mutation in the intracellular gate, which also favored inward-
open and outward-closed states, although the mutation stabilized a more open 





























Crystal      
(Å) 
239/480 0.56 0.64 0.72 4 5 9 3 6 9 
7/86 0.49 0.56 0.73 4 10 14 N/A N/A 17**  
309/480 0.68 0.76 0.81 7 13 20* 5 7 12 
Table 4.1 Comparison of distance changes predicted from FRET values versus crystal 
structures at both faces.  * Likely overestimated because it is at the ceiling of the FRET 
range. ** Measured between residues 11 and 86 because residue 7 is not resolved in the 
crystal structure. 
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suggesting an additional impact of the destabilizing mutation 6. This effect of intracellular 
gate mutations to promote more inward-open conformations than those appreciably 
populated by the wild-type transporter has also been demonstrated in EPR studies 49. 
Notably, such a mutation, as well as mutations of the Na2 site, was essential to capture 
the inward-open crystal structure 1. 
 
4.2.2. Na+ induces conformational changes to more compact states 
 
To examine the role of each FRET state in the transport mechanism, we measured 
conformational dynamics in the presence of the co-transported ion Na+. Consistent with 
previous findings 3,6,49, we found that Na+ stabilizes the intracellular high-FRET state, 
reducing the overall rate of dynamics. Occupancy of the low-FRET state was decreased, 
Figure 4.4 Na+ promotes higher FRET states at the extracellular and intracellular face. 
(a, b) FRET values from all filtered traces were summed into histograms. Na+ increased the 
occupancy of higher FRET states at both faces. (c, d) The fraction of time in the low, mid, and 
high-FRET states. Na+ decreased the occupancy of the low-FRET state at both faces, and 
increased the occupancy of the mid and high-FRET states at the extracellular face, but only 
the high-FRET state at the intracellular face. Lines are fits to Hill equation with low-FRET 
EC50 = 70 mM inside and 33 mM outside, n = 2.  (e, f) Transition density: average FRET 
values before (x axis) and after (y axis) each transition were plotted as a two-dimensional chart 
in transitions per second (color scale at right). Transitions per minute (t/m) are also reported. 
Na+ decreased intracellular dynamics but increased extracellular dynamics. 
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while the mid-FRET state occupancy 
remained low regardless of Na+ 
concentration (Figure 4.4a, c, e, Figure 
4.5a). 
At the extracellular face, Na+ 
decreased occupancy of the low-FRET 
state, favoring both mid- and high-FRET 
states (Figure 4.4b, d). As Na+ also 
stabilizes the inward-closed state, this 
finding suggests that the extracellular 
high-FRET state is not strictly inward-
facing, but also can occur in a state that is 
closed on both sides. Such a conformation has yet to be observed crystallographically and 
may represent a novel intermediate. Unlike its effect of slowing dynamics at the 
intracellular face, Na+ promoted more rapid dynamics at the extracellular face (Figure 
4.4f), principally by increasing the rate of transitions out of the low-FRET state (Figure 
4.5b). The opposite effect of Na+ on dynamics at each face, as well as the existence of a 
state that is closed on both sides, is not consistent with a rigid-body model of transport 
46,47, but rather suggests that these extracellular and intracellular microdomains can move 
independently and must be organized into an allosteric mechanism to coordinate Na+-
dependent transport.  
Na+ also decreased low-FRET occupancy and favored mid- and high-FRET states 
between EL4 and TM12 (A309C/H480C) (Figure 4.6b). This finding is consistent with 
Figure 4.5 Effects of Na+ on dynamics at 
each face. (a) At the intracellular face, Na+ 
reduced dwelltimes in the low-FRET state and 
increased dwelltimes in the high-FRET state. 
(b) At the extracellular face, Na+ reduced 
dwelltimes in the low-FRET state.  
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the observation that TM6a and EL4 are both relocated towards TM12 from their positions 
in the outward-open crystal structure 1 to close the extracellular face in the outward-
facing occluded 4 and outward-closed 1 structures. 
Together, these data suggest that Na+ binds to the outward-open state (low-FRET) 
from the extracellular side to stabilize the inward-closed (high-FRET) state and promote 
transitions to extracellular compact and closed states (mid- and high-FRET). In contrast, 
when LeuT is inward-open, Na+ either cannot bind or has no effect 3. This suggests that 
the Na+ binding sites are unstructured in the fully inward-open (intracellular low-FRET) 
state, consistent with the crystal structure 1, while they are competent for Na+ binding in 
the outward-open (extracellular low-FRET) state.  
Our finding that Na+ decreases the distance between EL4 and TM12 is unexpected 
given previous simulations 21,71 of the effect of Na+ to promote outward-open states, as 
well as EPR studies that measured an increased distance between the same labeling sites 
in the presence of Na+ 48,49. The divergence in findings must relate to one or more of the 
many methodological differences between these studies. The current finding that Na+ 
partially closes the extracellular face seems somewhat paradoxical given that Na+ drives 
Figure 4.6 Convergent results with additional extracellular labeling site supports validity 
of extracellular findings. (a) A309C/H480C-LeuT was labeled with self-healing Cy3 and 
Cy5 fluorophores (stars). (b) Na+ increased the occupancy of higher FRET states. (c) Ala in 
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transport and thus must allow substrate binding from the extracellular milieu. We 
hypothesized that the substrate-binding site might remain solvent-accessible in the 
extracellular compact (mid-FRET) state, which may correspond to a structure properly 
organized to bind substrate. Indeed, the substrate-binding site in the outward-facing 
occluded crystal structure is occluded by only a single residue (F253) 4, suggesting that 
the site may not be fully occluded, especially for the smaller substrate alanine (Ala). 
Thus, although there is likely no access to the substrate site in the extracellular high-
FRET state, based on its presumed correspondence to the outward-closed crystal structure 
that is occluded by a thick extracellular gate, transitions to the mid-FRET state might still 
enable substrate binding to the S1 site as well as play a role in organizing the S2 site, 
which is also Na+-dependent.  
We tested whether the rate of Leu binding might be slowed by pre-incubation 
with Na+ as compared to simultaneous co-addition of Na+ and Leu. Indeed, consistent 
with an impairment of 
access we observed a 
substantial slowing of Leu 
binding when the 
transporter was pre-
equilibrated with Na+ 
(Figure 4.7a).  In contrast 
to bulky Leu, which is a very poor substrate, the smaller Ala binds in an indistinguishable 
manner independent of the timing of Na+ addition (Figure 4.7b). These findings are 
Figure 4.7 Preincubation of LeuT with Na+ decreases the 
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consistent with the Na+-induced mid-FRET state at the extracellular face corresponding 
to a more compact configuration, but one that is competent to bind the substrate Ala. 
 
4.2.3. Alanine accelerates dynamics at both faces of LeuT and favors intermediate 
states. 
We next examined the effects of substrate on the conformational dynamics at both 
faces of LeuT. To better detect the effects of Ala, we used a relatively low concentration 
of Na+ (5 mM). This also more closely reproduced the effects of a Na+ gradient, in which 
the transporter is expected to populate both Na+-bound and unbound states 3.  
Figure 4.8 Alanine promotes higher FRET states and dynamics at each face. (a-d) Ala in 
the presence of 5 mM Na+ decreased the occupancy of the low-FRET state and increased the 
occupancy of the mid and high-FRET states at both faces. Lines in (c, d) are fits to Hill 
equation with low-FRET EC50 = 269 µM inside and 26 µM outside, n = 2. (e, f) Ala increased 
dynamics at both faces. (g) At the intracellular face, the majority of transitions in the absence 
of Ala occurred between low- and high-FRET states, while the majority of Ala-induced 
transitions occurred between mid- and high-FRET states. (h) At the extracellular face, the 
majority of Ala-induced transitions were between low- and high-FRET (left) or between low- 
and mid-FRET (right). 
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At the intracellular face, Ala decreased the occupancy of the low-FRET state, 
favoring mid- and high-FRET states (Figure 4.8a, c). Because the low- and mid-FRET 
states could not be differentiated in prior work, this effect of Ala was previously observed 
as an increase in the mean FRET value of the lower-FRET state 3. Consistent with our 
previous findings, Ala increased the overall rate of dynamics (Figure 4.8e) by subtly 
reducing the time spent in all states (Figure 4.9a). The majority of transitions in the 
absence of ligands occurred between low- and high-FRET states, while the majority of 
Ala-induced transitions occurred between mid- and high-FRET states (Figure 4.8e, g, 
Figure 4.9b). These findings suggest that the intracellular mid-FRET state is specific to 
the presence of substrate, either corresponding to substrate binding or to a later step in 
transport, while the low-FRET state is specific to the apo transporter, and the high-FRET 
state can be visited 
under various 
ligand conditions.  
At the 
extracellular face, 
Ala decreased the 
occupancy of the 
low-FRET state in 
favor of mid- and 
high-FRET states 
(Figure 4.8b, d), 
consistent with the 
Figure 4.9 Effects of Ala on dynamics at each face. (a) At the 
intracellular face, Ala subtly reduced dwelltimes in all states, and (b) 
increased the proportion of transitions between mid- and high-FRET, but 
decreased the proportion of transitions between low- and high-FRET. (c) 
At the extracellular face, Ala reduced dwelltimes in all states, particularly 
low-FRET. (d) The majority of extracellular transitions occurred between 
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reduction in distances between extracellular sites observed with double electron-electron 
resonance (DEER) upon addition of substrate in the presence of Na+ 48,49. This result is 
also similar to the effect of Na+ alone, but Ala increased the overall rate of dynamics 
much more than Na+ alone (Figure 4.8f). Ala reduced the time spent in all states, 
particularly increasing the rates of transitions out of the low-FRET state (Figure 4.9c); 
thus, the majority of transitions were between low-FRET and mid- or high-FRET (Figure 
4.8f, h, Figure 4.9d). The effects of Ala were similar at EL4/TM12 (Figure 4.6c, d).  
We also examined the effects of Leu, a poor substrate that is transported ~10-fold 
more slowly than Ala 21,32. Whereas Leu also promoted a shift to mid- and high-FRET 
states on the extracellular side, consistent with formation of outward-occluded and closed 
conformations (Figure 4.10b, d), unlike Ala, Leu decreased the rate of extracellular 
dynamics (Figure 4.10f). Similarly, we previously showed that Leu decreases 
intracellular dynamics in contradistinction to Ala 3, a result that we reproduced here 
Figure 4.10 Leucine promotes higher FRET states but decreases dynamics at each face. 
(a-d) Leu in the presence of 5 mM Na+ decreased the occupancy of the low-FRET state at 
both faces, and increased the occupancy of the mid and high-FRET states at the extracellular 
face, but only the high-FRET state at the intracellular face. (e, f) Leu decreased dynamics at 
both faces.  
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(Figure 4.10e). Interestingly, our improved resolution of intracellular FRET states in the 
current study revealed that, whereas Ala promoted both mid- and high-FRET states at the 
intracellular face, Leu promoted only the high-FRET state without increasing occupancy 
of the mid-FRET state (Figure 4.10a, c). We attribute the differences in conformational 
dynamics induced by Ala versus Leu to the very poor transportability of Leu. Leu may 
prevent the appropriate integration of the microdomains, both by impeding intracellular 
and extracellular opening and by stabilizing a bound doubly occluded state.  
These findings suggest that both the intracellular and extracellular low-FRET 
states are specific to the apo transporter. However, unlike the intracellular mid-FRET 
state, which is observed only in the presence of the well-transported substrate Ala, the 
extracellular mid-FRET state is observed in the presence of Na+ alone as well as with the 
very poor substrate Leu. This implicates the mid-FRET state on the intracellular side in 
the transport process, as it occurs only under conditions that support transport.  
 
4.2.4. Li+ does not support the same Ala-induced conformational dynamics as Na+ 
 
To test this hypothesis, we next examined whether Ala binding without transport 
is sufficient to induce the above-described conformational changes, or whether the 
intracellular mid-FRET state can be established as a critical intermediate in the transport 
mechanism. We previously showed that replacing Na+ with Li+ does not affect Ala 
binding affinity or stoichiometry, but eliminates transport as well as Ala-induced 
intracellular smFRET gating dynamics 3. Here, we found that much like Na+, Li+ 
decreased low-FRET state occupancy at both faces of LeuT. At the intracellular face, Li+ 
favored the high-FRET state but did not increase mid-FRET state occupancy, similarly to 
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the effects of Na+ 
(Figure 4.11a, 
c). At the 
extracellular 
face, Li+ favored 
both the mid- and 
high-FRET states 
(Figure 4.11b, 
d), also similarly 
to Na+.   
However, despite the similar effects of Na+ and Li+ when applied alone, the 
addition of Ala revealed substantial differences in Li+-supported dynamics. At the 
intracellular face, Ala in the presence of Li+ favored the high-FRET state, but unlike in 
the presence of Na+, it failed to increase mid-FRET state occupancy (Figure 4.12a, c). 
Rather than increasing the rate of intracellular dynamics by promoting transitions 
between mid- and high-FRET states, Ala in the presence of Li+ decreased intracellular 
dynamics (Figure 4.12e). Thus, at the intracellular face the effects of Ala in the presence 
of Li+ are similar to the effects of Leu in the presence of Na+. Both of these conditions 
promote substrate binding without transport, supporting the hypothesis that the 
intracellular mid-FRET state is a specific correlate of transport. In contrast, at the 
extracellular face in the presence of Li+, Ala favored both mid- and high-FRET states 
(Figure 4.12b, d) and increased transitions between low-FRET and mid- and high-FRET 
states (Figure 4.12f), similarly to the effects of Ala in the presence of Na+. 
Figure 4.11 Li+ decreases low-FRET occupancy at both faces. Lines in 
(c, d) are fits to Hill equation with low-FRET EC50 = 100 mM inside and 
150 mM outside, n = 2.  
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These findings suggest that the intracellular mid-FRET state corresponds to a 
critical intermediate in the transport cycle that can be accessed only under conditions 
supporting transport. The ability to achieve this state may indicate the transportability of 
a substrate. Simulations have indicated that Li+ binding to the Na+ sites does not produce 
the same set of local rearrangements as Na+ 3. These differences may result in an inability 
to undergo the structural rearrangements necessary for isomerization to the substrate-
bound inward-facing intermediate state, ultimately inhibiting transport by stabilizing the 
state prior to this transition (inward-closed, high-FRET). Indeed, the FRET values of the 
intracellular low- and high-FRET states were altered in the presence of Li+ compared to 
apo and Na+ conditions, suggesting subtle structural differences between these 
configurations. 
 
Figure 4.12 Li+ supports Ala-induced dynamics at the extracellular face but not the 
intracellular face. (a-d) Ala in the presence of 100 mM Li+ decreased the occupancy of the 
low-FRET state at both faces, and increased the occupancy of the mid and high-FRET states at 
the extracellular face, but only the high-FRET state at the intracellular face. Lines in (c, d) are 
fits to Hill equation with low-FRET EC50 = 173 µM inside and 27 µM outside, n = 2. (e, f) Ala 
increased dynamics at the extracellular face but decreased dynamics at the intracellular face.  
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4.3 Discussion 
 
Taken together, our data suggest a more complete model of the transport 
mechanism that includes the conformational states at both faces of the transporter 
throughout the transport cycle. In the absence of Na+ (Figure 4.13a), an unnatural 
situation for a plasma membrane transporter that is typically exposed to a high external 
Na+ concentration (~150 mM), LeuT spontaneously transitions between outward-
open/inward-closed and inward-open/outward-closed states, which correspond to the 
Figure 4.13 Schematic of the transport cycle derived from smFRET data. (a) In the 
absence of Na+, LeuT spontaneously transitions between outward-facing and inward-facing 
states, with significant average occupancy of low-FRET states on each side. (b) Na+ binding 
(yellow circles) stabilizes the intracellular high-FRET (closed) state and favors the 
extracellular mid- and high-FRET states. The extracellular high-FRET state may be fully 
occluded, while the substrate-binding site may be at least partially accessible in the mid-FRET 
state. (c) Binding of Ala (orange triangles) facilitates faster transitions to extracellular mid- 
and high-FRET states. (d) On the intracellular side, transitions to an inward-facing mid-FRET 
state enable inward release of substrate. The unloaded transporter can then return to 
extracellular-facing states to repeat the cycle via the intracellular low-FRET state. (e) 
Alternatively, reloading of the S1 site by the second substrate in the presence of Na+ may 
promote a faster return step. 
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low- and high-FRET states at each face. Na+ binding (Figure 4.13b) stabilizes the 
inward-closed state (high-FRET) by slowing transitions to inward-facing (mid- and low-
FRET) states that might otherwise allow Na+ translocation in the absence of substrate 
transport. At the extracellular face, Na+ promotes transitions out of low-FRET to mid- 
and high-FRET states, which we hypothesize represent compact and closed 
conformations at the extracellular face, respectively. While initially seeming paradoxical, 
the observation of a more compact extracellular face is supported by our findings of 
slower Leu binding when LeuT is pre-equilibrated with Na+. Interestingly, this was not 
the case with the smaller substrate Ala, suggesting that Na+ can in fact prepare the 
transporter for substrate binding to both the S1 and S2 sites, facilitating transport. A more 
compact configuration in Na+ may also confer an advantage by decreasing ion leaks that 
might occur with rare simultaneous openings of both sides of the transporter. Indeed, in 
SERT, Na+ has been demonstrated to reduce leak currents 72, suggesting that Na+-induced 
closure at both faces might have a physiological role in limiting uncoupled ion 
movements through the transporter 
As EPR studies have indicated that the N-terminal segment (residues 1-10) moves 
to a different extent than the rest of TM1a, and that the mutations and detergent 
conditions of the inward-open crystal structure affect the degree of inward-opening, we 
also compared our smFRET distance measurements to the DEER findings for H7C/R86C 
LeuT 49. DEER indicated a distance change of ~25 Å from the inward-closed to the 
inward-open state, a greater distance change than our smFRET data indicated (14 Å). 
Like the discrepancies between our findings and DEER data on the effects of Na+ on 
A309C/H480C 49, this difference must relate to the methodological differences between 
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these studies. However, DEER data on the general effects of Na+ and Na+/Leu on 
H7C/R86C were consistent with our smFRET findings 49. 
Our data suggest that substrate binding in the presence of Na+ (Figure 4.13c) 
increases the rate of extracellular transitions from outward-open (low-FRET) to outward-
compact and closed states (mid- and high-FRET, respectively). At the intracellular face, 
substrate binding enables transitions from inward-closed (high-FRET) to an inward-
facing state (mid-FRET) that is only observed during transport (Figure 4.13d). Inward 
release of substrate and Na+ might occur from this state, or might be facilitated by 
sampling of the fully inward-open (low-FRET) state.  
At the intracellular face, transitions involving the low-FRET state, which likely 
corresponds to the apo state, are not appreciably detected in the presence of substrate. It 
is possible that the low-FRET (apo) state is bypassed, and S1 substrate release occurs 
from the mid-FRET state while the S2 substrate remains bound. In the presence of high 
Na+ concentrations in the extracellular environment, the S2 substrate might then move 
into the S1 site to reload the transporter, promoting a faster return step (Figure 4.13e). 
  Alternatively, under these experimental conditions in the absence of a gradient, 
fast re-binding of ligands might obscure possible visits to the intracellular low-FRET 
(apo) state, accounting for the predominance of mid- and high-FRET states in the 
presence of substrate. Further insights into the complete transport cycle will require 
smFRET studies of LeuT reconstituted into proteoliposomes, in which ligand gradients 
can be applied to provide more detailed insights into specific steps of inward release and 
the return of the unloaded transporter. 
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Li+ binding, much like Na+, stabilizes the inward-closed (high-FRET) state, 
promotes the outward-compact and closed (mid- and high-FRET) states, and enables Ala 
binding, which increases the rate of extracellular transitions from low to mid- and high-
FRET states. Unlike Na+, however, Li+ does not support substrate-induced transitions 
from inward-closed (high-FRET) to inward-facing intermediate (mid-FRET) states, thus 
preventing inward release and transport (Figure 4.13d). This finding suggests that the 
distinct set of local rearrangements promoted by Na+, which are not produced by Li+ 3, 
are required for this intracellular transition, but are not required for extracellular ligand-
induced transitions to higher FRET states. Thus, the inward-facing intermediate state is a 
necessary stage in substrate transport, and the ability to access this state may be a key 
determinant of the transportability of substrates.  A conformation corresponding to the 
mid-FRET state has not been crystallized in LeuT, but the distance change is similar to 
that observed in simulations of LeuT inward-opening as substrate is pulled intracellularly 
6. 
Our data indicate that each face of LeuT can demonstrate independent ligand-
modulated conformational dynamics. Based on the pseudo two-fold symmetry of TMs 1-
5 and 6-10, as well as the organization of TMs, 1, 2, 6 and 7 into a four-helix bundle, it 
has been previously proposed that these core helices of LeuT move as a rigid body, 
causing one face to open when the opposite face closes 47. However, recent crystal 
structures of LeuT in inward-open and outward-open states 1 have shown that the 
extracellular and intracellular regions of some helices move to different extents, 
suggesting that they can bend flexibly, and this model is supported by EPR studies 49.  In 
addition, our previous smFRET studies 6 have shown that an extracellular gate mutation 
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affects the configuration of the extracellular face to a much lesser extent than that of the 
intracellular face, indicating that the transport mechanism involves an organized cascade 
of local rearrangements rather than a single rigid-body movement. Our smFRET data 
from the current study support this model of flexible motions between the two faces. To 
further resolve the mechanism of coupling between the two sides, simultaneous smFRET 
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5. PROTON-MODULATED GATING DYNAMICS AT THE EXTRACELLULAR 





In addition to Na+, most eukaryotic NSS also symport Cl- 28,73-76. The binding of both 
substrates and inhibitors is Cl—dependent 77, and the transport rate is faster with higher 
Cl- concentration 28. In contrast, all prokaryotic NSS studied to date are Cl—independent 
78. Transport by the prokaryotic NSS Tyt1 and MhsT alkalinizes the interior of cells or 
liposomes, and application of a reverse proton gradient accelerates transport 29, indicating 
that H+ antiport may facilitate the return step of the empty transporter from an inward-
facing to an outward-facing state, and that this step might be rate-limiting to transport.  
A putative Cl--binding site in eukaryotic NSS was originally proposed near the Na1 
site on the basis of comparison to the Cl- site in the crystal structure of a Cl-/H+ 
antiporter, pKa calculations, homology modeling, and mutagenesis 79. Interestingly, while 
Cl--dependent eukaryotic NSS have a polar residue at this position (equivalent to residue 
286 or 290 in LeuT), Cl--independent prokaryotic NSS that antiport H+ have an acidic 
residue instead 28, which may become protonated and deprotonated during the transport 
cycle. Simulations have suggested that protonation of E290 in LeuT in the inward-facing 
state and deprotonation in the outward-facing state are facilitated by conformation-
dependent alterations in the pKa of this residue 29.  
The dependence on Cl- symport or H+ antiport can be interchanged between 
eukaryotic and prokaryotic NSS by substituting either a polar or acidic residue at this 
position. In LeuT, mutation of E290 to serine confers Cl--dependent Na+ and substrate 
binding (transport was too slow to be accurately measured) 5, and similar substitutions 
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confer Cl--dependent transport in other prokaryotic NSS (in which transport is faster and 
thus more easily measured) 30.  Conversely, mutation of S331 in GAT-1 (equivalent to 
residue 290 of LeuT) to glutamate makes GAT-1 transport pH-dependent 28, suggesting 
that the negatively charged side chain of glutamate fulfills the role of Cl-.  
The E290S mutant of LeuT was crystallized with Cl- coordinated by Ser290, in 
addition to other residues 5, providing further support for the proposed location of the Cl- 
binding site in eukaryotic NSS. The location of the site was confirmed when dDAT was 
crystallized with Cl- bound in the equivalent site 27, further validating the use of LeuT as 
a model for eukaryotic NSS.  
Binding studies and 
simulations suggest that in the 
outward-facing state, the 
negative charge provided by 
either bound Cl- or a 
deprotonated acidic residue 
might promote Na+ binding, as 
this negative charge is in close 
proximity to the Na1 site 
5,28,42,71. In the inward-facing 
state, neutralization of the negative charge, either by release of Cl- into the cell by 
eukaryotic NSS, or protonation of the acidic residue in prokaryotic NSS, might promote 
the return step to the outward-facing state. By this reasoning, Cl- symport in eukaryotes 
and H+ antiport in prokaryotes may be analogous mechanisms (Fig. 5.1).  
Figure 5.1 Cl- symport and H+ antiport as analogous 
mechanisms. (a) The Cl--dependent transporter (T) binds 
Cl- from outside the cell (left), promoting the binding of Na+ 
and substrate (S), and releases ligands to the inside (right). 
The neutralized transporter returns to the outward-facing 
state. (b) The H+-dependent transporter has a negative 
charge (T-) that promotes Na+ and substrate binding from 
outside the cell (left), and the ligands are released to the 
inside (right). Neutralization by protonation (TH) promotes 
the return step. Figure from 2. 
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We tested the hypothesis that protonation promotes the return of the empty 
transporter from the inward-facing to the outward-facing state, using smFRET imaging to 
directly examine the effects of pH on the conformational dynamics at the intracellular 
and extracellular faces of LeuT.  
 
5.2 Results 
5.2.1 Protonation induces opposite effects on conformational dynamics at each face 
We observed opposite effects of pH on the smFRET distributions at each face of 
LeuT. smFRET measurements were made between the N-terminal segment and IL2 at the 
intracellular face (H7C/R86C) and between TM6a and TM12 at the extracellular face 
Figure 5.2 Protonation has opposite effects at each face. Decreasing pH promotes the 
intracellular high-FRET (a, c) and extracellular low-FRET (b, d) states, and increases 
intracellular dynamics (e) by promoting inward-closing transitions (g), while decreasing 
extracellular dynamics (f) by stabilizing the outward-open state (h). Lines in (c, d) are fits to 
Hill equation with low-FRET EC50 = 7.3 inside and 8.0 outside, n = 2. 
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(K239C/H480C), using self-healing fluorophores with high SNR (see Chapters 3 and 4). 
In the absence of Na+ and substrate, at high pH (8.5) the intracellular face showed greater 
occupancy of the low-FRET state compared to the mid- and high-FRET states (Fig. 5.2a, 
c). Decreasing the pH decreased the occupancy of the low-FRET state and increased the 
occupancy of the high-FRET state, suggesting that protonation promotes an inward-
closed conformation. Occupancy of the mid-FRET state remained low regardless of pH, 
supporting the assignment of this state to a substrate-bound intermediate (see Chapter 4). 
The EC50 of the pH effect on state occupancy was 7.3, yielding an estimate of the pKa of 
the functionally relevant titratable residue(s), similar to the pKa of 7.6 calculated for E290 
in the inward-open conformation based on simulations 5.  
In contrast to the intracellular face, the extracellular face showed increased occupancy 
of the low-FRET state and decreased 
occupancy of the mid- and high-FRET 
states with decreasing pH, with an EC50 
of 8.0 (also similar to the pKa calculated 
for E290 in simulations 5) (Fig. 5.2b, d), 
suggesting that protonation promotes an 
outward-facing conformation. These 
results are consistent with the hypothesis 
that protonation facilitates the return step 
of the apo transporter from an inward-
facing to an outward-facing conformation. 
Protonation also had opposite effects 
Figure 5.3 Effects of protonation on 
dynamics at each face. (a) At the intracellular 
face, low pH primarily reduced dwelltimes in 
the low-FRET state.  (b) At the extracellular 
face, low pH increased dwelltimes in the low-
FRET state.  
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on the dynamics at each face. At the intracellular face, reducing the pH from 8.0 to 6.5 
increased dynamics by promoting inward-closing transitions (Fig. 5.2e, g, Fig. 5.3a). In 
contrast, at the extracellular face reducing the pH decreased dynamics by stabilizing the 
outward-open (low-FRET) state (Fig. 5.2f, h, Fig. 5.3b).  
 
5.2.2 The transport rate is fastest in the presence of a pH gradient 
As described above, the 
intracellular face exhibited 
increased dynamics at low 
pH, while the extracellular 
face exhibited increased 
dynamics at high pH. Under 
a pH gradient with higher 
extracellular and lower 
intracellular pH, both faces 
of LeuT would be expected to exhibit maximal dynamics.  Consistent with this 
hypothesis, we observed the fastest rate of 3H-Ala uptake by LeuT reconstituted into 
proteoliposomes at high external pH (8) and low internal pH (6), in the presence of 
external Na+ (Fig. 5.4). This pattern of pH dependence is similar to the prokaryotic NSS 
Tyt1, which exhibits maximal transport rates at external pH 8.5 and internal pH 6.5 29.  
 
5.3 Discussion 
Our smFRET findings support the hypothesis that in the H+-dependent NSS, 
protonation promotes the return step of the apo transporter from the inward-facing to the 
Figure 5.4 3H-Ala uptake is fastest under a pH gradient. 
(a) LeuT was reconstituted into proteolipomes in the 
presence of external Na+ and Ala and various pH conditions. 
(b) A pH gradient with high external and low internal pH 
produced the fastest transport rate. 
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outward-facing state. Binding studies and simulations 5,28,42,71 suggest that a negative 
charge near the Na1 site in the outward-facing state promotes Na+ binding. However, 
after the inward release of Na+ and substrate, the negative charge might prevent inward-
closing due to the unfavorable energetics of burying a charge in the protein core. 
Therefore, neutralization of the negative charge is expected to facilitate inward-closing, 
which would allow outward-opening. This hypothesis was supported by our smFRET 
finding that reducing the pH increases the rate of inward-closing transitions and the 
length of time spent in an outward-open conformation. Mutations in LeuT and eukaryotic 
NSS demonstrate that Cl- binding can fulfill the role of the negatively charged residue 
28,5,30,29, suggesting that Cl- symport might play a similar role in the eukaryotic NSS 
transport cycle.   
A crystal structure of the Cl--dependent E290S LeuT mutant bound to Cl- was 
recently solved 5, demonstrating that the anion is coordinated by Ser290, as well as by 
Tyr47, Thr254, and Gln250. Similarly, the crystal structure of dDAT showed Cl- 
coordination by Ser320, which is in a position equivalent to 290, in close proximity to the 
Na1 site 27. Parallel simulations of both E290S and wild-type LeuT 5 showed that the 
negative charge at position 290 participates in a local interaction network of Tyr47 and 
Gln250 with extracellular gate residues Arg30 and Asp404, which maintains an outward-
occluded state in the presence of Na+ in the Na1 and Na2 sites and substrate in the S1 site 
(Figure 5.5a, b). Neutralization of this negative charge weakens the interaction between 
Glu290 and Gln250, leading to extracellular water penetration and local reorganization 
that is propagated to the conserved interface between TM2 and TM6a, presumably 
causing outward-opening (Figure 5.5c, d).  
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Comparison of the E290S 5 and WT outward-occluded crystal structures 4 is 
consistent with the simulations, as the extracellular gate between R30 and D404 is closed 
by a salt bridge in the Cl--bound E290S structure, while it is open in the WT structure, 
which has a protonated E290.  Although the simulations were performed in the presence 
of Na+ and substrate while our smFRET studies were performed under apo conditions, 
this is consistent with our smFRET finding that decreasing the pH promotes outward-
open conformations.  
To test the hypothesis that the effects of pH we observed are due to protonation 
and deprotonation of residue E290, it would be informative to conduct smFRET studies 
of the Cl--dependent E290S mutant. These studies would also enable us to test the 
hypothesis that Cl- has an analogous effect in the Cl--dependent NSS. However, we were 
Figure 5.5 Simulations show the role of a negative charge at position 290. (a) In the E290S 
LeuT mutant, Cl- maintains an interaction network near the Na1 and S1 sites. (b) In the WT, 
deprotonated E290 fulfills the same role. (c) In E290S in the absence of Cl-, Q250 rotates and 
allows extracellular water penetration. (d) A similar effect is seen in the WT when E290 is 
protonated.  Figure adapted from 5. 
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unable to obtain usable smFRET data with this mutant due to poor photophysical 
properties.  
Our smFRET data showed that the extracellular face of apo LeuT exhibited the 
most transitions at high pH, while the intracellular face was most dynamic at low pH. By 
analogy in eukaryotic NSS, we might expect the extracellular face to be most dynamic 
under high Cl- concentrations and the intracellular face to be most dynamic under low Cl-- 
concentrations.  Thus, each face would be most dynamic under the opposing conditions 
expected in the physiological extracellular and intracellular environments, which might 
facilitate the harnessing of the energy of ligand gradients in substrate transport. This is 
consistent with our smFRET data showing that the extracellular face is most dynamic at 
higher Na+ concentration, while the intracellular face is most dynamic in the absence of 
Na+ (Chapter 4), which also corresponds to the physiological ion gradient. SmFRET 
studies of LeuT reconstituted into proteoliposomes, in which ligand gradients can be 
applied, will provide further insight into the conformational dynamics associated with the 
gradient-driven transport mechanism of the NSS family. 
In contrast to popular models positing that the core helices of LeuT move as a 
rigid body 46, the inward-facing and outward-facing crystal structures of LeuT 1 
demonstrate that the extracellular and intracellular regions of some helices can move to 
different extents, suggesting that they bend flexibly. Our smFRET findings provide 
additional evidence that the intracellular and extracellular faces of LeuT move 
independently, suggesting that each face can be regulated separately. Transporters might 
have evolved as a collection of allosterically coupled microdomains rather than a single 
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rigid body because this confers greater flexibility of physiological regulation. Taking 
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6. CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 Conclusions  
Neurotransmitter:sodium symporters regulate the spatial and temporal 
characteristics of signaling in the brain by taking up neurotransmitters from the synaptic 
cleft into the pre-synaptic neurons after each signaling event, using the physiological Na+ 
gradient to concentrate neurotransmitters inside the cell. Thus, these transporters are 
important pharmacological targets. Although crystal structures, biochemical studies, and 
EPR studies have provided significant insight into the transport mechanism, the 
conformational transitions that occur during the transport cycle and the effects of ligands 
on these transitions remain poorly understood. Single-molecule imaging methods, 
particularly smFRET, are powerful tools capable of revealing these conformational 
dynamics in proteins.  
The Javitch and Blanchard groups have used smFRET to study the effects of 
ligands on conformational dynamics at the intracellular face of LeuT, a prokaryotic NSS 
homolog that is a valuable model system 3,6. However, the technical challenges of 
smFRET imaging at the extracellular face, where the SNR is lower, did not previously 
allow exploration of the relationship between dynamics at the intracellular and 
extracellular faces. In this dissertation, I have described advances in smFRET 
methodology enabling the imaging of conformational dynamics at the extracellular face 
of LeuT for the first time, and I have examined the relationship between the dynamics at 
the two faces under different ligand conditions. This research has demonstrated that the 
two faces of LeuT do not move as a rigid body, as has been proposed by some groups 
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46,47, but instead move flexibly, presumably around hinge-like regions at the unwound 
portions of transmembrane helices 1.  
These studies have informed our model of the transport cycle by indicating the 
effects of ligands on conformational states at both faces of the transporter. Our smFRET 
data led to the novel prediction that Na+ promotes more compact states at the 
extracellular face, while still allowing some extent of access to the substrate binding sites, 
and this prediction was supported by functional data from radioligand binding studies. 
Our smFRET data have also revealed previously undetected intermediate states that are 
specific correlates of substrate transport activity and have yet to be captured 
crystallographically. 
 Despite these advances, further studies are necessary to resolve the mechanism of 
coupling between the two faces that produces the alternating access mechanism, 
preventing ligands from running down their electrochemical gradients. In addition, 
smFRET studies in liposomes, in which ligand gradients can be applied, will elucidate 
the transport mechanism under more physiological conditions.  
 
6.2 Future Directions 
 
6.2.1 Mutations to disentangle the role of each ligand-binding site 
 LeuT has two Na+ binding sites, but the role of each site in transport has not been 
established. There is evidence that Na2, which is located in a more intracellular position, 
is readily released into the cell from an inward-closed conformation. This suggests that 
Na2 release precedes inward-opening and the release of Na1 and the S1 substrate, which 
are in direct contact and mutually stabilize each other’s binding to LeuT 21. The Na2 site 
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is conserved among transporter families with a LeuT-fold even in the absence of 





functions of the 
Na1 and Na2 
sites, smFRET 
studies will be 
carried out in 
LeuT with 
mutations 
eliminating Na+ binding to either site. Na1 (N27A) and Na2 (T354A) site mutants 
(Figure 6.1a) have been functionally characterized, demonstrating that the stoichiometry 
of 22Na+ binding is reduced from two to one, and that transport is eliminated (data not 
shown). While Na+ promotes higher FRET states at both faces of the wild-type 
transporter (Chapter 4), preliminary smFRET data from 7C/86C- and 239C/480C-
labeled Na+ site mutants show that mutation of either site eliminates the effect of Na+ on 
the FRET distribution (Figure 6.2).  This finding indicates that both Na+ sites must be 
intact in order for Na+ to promote more compact states at each face.  
Interestingly, although Na+ decreases dynamics at the intracellular face of the 
wild-type transporter by stabilizing inward-closed states (Chapter 4), preliminary 
Figure 6.1 Residues that were mutated in (a) Na1 (N27) or Na2 (T354) 
sites and (b) S1 (F253) or S2 (L400) sites.  Figure adapted from 3 and 4 
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smFRET data indicate that Na+ increases intracellular dynamics in both Na+ site mutants 
(Figure 6.3a), suggesting that Na+ promotes brief visits to high-FRET states but that both 
sites must be intact in order to stabilize the inward-closed state.  
At the extracellular face, Na+ increases dynamics in the wild-type transporter by 
increasing the rate of transitions out of the outward-open state into more compact states 
(Chapter 4). Na+ also increases dynamics in the Na2 site mutant (Figure 6.3b), despite 
its failure to shift the overall FRET distribution to higher FRET states, suggesting that 
these higher FRET states are unstable in the mutant. In contrast, Na+ does not affect 
dynamics or FRET distribution in the Na1 site mutant. This suggests that Na+ binding to 
the Na1 site is necessary and sufficient to promote extracellular transitions to higher 
FRET states, but that in the absence of Na+ bound in the Na2 site these states are 
unstable. The effects of Na+ on the kinetics of transitions between specific states in these 
mutants will be examined in more detail in further studies  
Figure 6.2 A mutation in either Na+ site eliminates the effect of Na+ on the FRET 
distribution. (a) In the WT, Na+ promotes more compact states (higher FRET) at each face. 
Mutations in the Na1 (b) or Na2 (c) site prevent a Na+-induced shift in FRET distribution.  
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Similarly, LeuT has two substrate-binding sites, and two substrates can bind 
simultaneously, although only one substrate molecule is released to the inside of the cell 
per transport cycle 3. There is evidence that substrate binding to the S2 site has an 
allosteric role in promoting inward-opening and intracellular release of Na1 and the S1 
substrate 3,21. To differentiate the roles of the S1 and S2 substrate sites, mutations have 
been made in each site: F253A and L400S, respectively (Figure 6.1b). Functional studies 
of these mutants have demonstrated that the stoichiometry of substrate binding is reduced 
from two to one, and that transport is eliminated 3. In addition, our group previously 
showed that mutation of either site greatly reduced Ala-induced intracellular smFRET 
dynamics 3. In preliminary smFRET studies, we have used high-SNR fluorophores at 
each face (see Chapters 3 and 4) in order to characterize the FRET states in the mutants 
with greater resolution.  
Figure 6.3 Effects of Na+ on dynamics in Na+ site mutants. (a) At the intracellular face, Na+ 
decreases dynamics in the WT but increases dynamics in both mutants. (b) At the extracellular 
face, Na+ increases dynamics in the WT and the Na2 site mutant (T354A) but does not 
appreciably affect dynamics in the Na1 site mutant (N27A).  
	  
	  
	   71	  
At the intracellular face, the S1 site mutation eliminates Ala-induced mid-FRET 
occupancy, but supports an Ala-induced shift to the high-FRET state (Figure 6.4a). This 
result is similar to the effect of substituting Li+ for Na+ in the presence of Ala at the 
intracellular face, consistent with the lack of transport in both scenarios. However, both 
the S1 and S2 site mutants have an altered conformational equilibrium between the states 
compared to the WT in the absence of substrate, making the interpretation of substrate 
effects difficult. The low-FRET state in the S1 mutant has a lower FRET value than in 
the WT, suggesting that this mutant accesses a more inward-open conformation, while 
the S2 mutant has negligible occupancy of the low-FRET state. The S2 mutant does not 
exhibit an Ala-induced shift in FRET distribution, perhaps because it primarily occupies 
the high-FRET state in the absence of substrate. This mutant also does not access the 
mid-FRET state, consistent with its inability to transport substrate. At the extracellular 
Figure 6.4 Substrate site mutations alter the response to Ala. (a) At the inside face in the 
presence of 50 mM Na+, Ala promotes mid- and high-FRET states in the WT, while in the S1 
mutant (F253A) Ala promotes high-FRET but not mid-FRET, and in the S2 mutant (L400S) 
Ala has no effect on FRET distribution. (b) At the outside face in the presence of 5 mM Na+, 
Ala promotes mid- and high-FRET states in the WT and mutants.  
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face, the effects of Ala on the FRET distributions of both mutants are similar to the WT, 
suggesting that binding of only one substrate at either site is sufficient to promote the 
Ala-induced shift to extracellular mid- and high-FRET states observed in the WT (Figure 
6.4b).  
As in the WT, Ala-induced increases in dynamics are observed in both mutants at 
each face; however, the increase in dynamics in the mutants is greatly reduced compared 
to the WT (data not shown). These dynamics will be characterized in future studies.  
 
6.2.2 Simultaneous imaging at both faces of LeuT using four-color smFRET 
All of the above-described smFRET studies have imaged each face of LeuT 
separately and made inferences about the overall conformation based on the relationships 
between FRET states and crystal structures, as well as correlations between changes in 
FRET state occupancy at each face. However, simultaneous smFRET imaging at both 
faces of LeuT would enable identification of the overall conformation with greater 
certainty. This can be achieved using four-color FRET, with a different donor and 
acceptor pair at each face.  
The use of four different fluorophores will require implementation of different 
site-specific labeling methods. For two-color FRET, we label double-cysteine mutants 
with a mixture of two maleimide-activated fluorophores, leading to stochastic labeling, in 
which only ~50% of the products (those labeled with one dye of each color) are usable. 
This stochastic labeling strategy would be inefficient for four-color labeling, yielding 
very few usable molecules. If double-cysteine labeling is used at one face, additional 
labeling strategies could be used at the opposite face. Strategies to be tested include 
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unnatural amino acid incorporation 81 as well as enzymatic labeling such as acyl carrier 
protein (ACP)-tag 82, Halo-tag 82 or SNAP-tag 83.  
 
6.2.3 smFRET of LeuT in proteoliposomes  
NSSs function under ion gradients, but all the above-described smFRET 
experiments were performed in detergent with both faces of the transporter exposed to 
identical buffer conditions. In order to elucidate the gradient-driven transport mechanism, 
we will perform smFRET studies of LeuT reconstituted into proteoliposomes, where 
gradients can be applied and transport can occur. Preliminary smFRET studies of the 
intracellular face of LeuT have been performed in proteoliposomes. Labeled H7C/R86C 
LeuT was reconstituted into 100 nm proteoliposomes composed of 1% biotin-CAP-PE, 
which were immobilized on a streptavidin-coated microscope slide. In the presence of a 
Na+ and pH gradient with external alanine, conformational transitions were detected on a 
timescale similar to that observed in detergent (data not shown).  
However, the SNR is reduced in proteoliposome studies, as fluorophore lifetimes 
are decreased in the lipid environment, and lipids create background fluorescence. Self-
healing fluorophores are essential, as COT in solution undermines the membrane 
integrity. In addition, the ion gradients cannot be maintained indefinitely (~40 min for 
100 nm liposomes). To enable observation of dynamics on the timescale of the 
fluorophore lifetimes, LeuT with a K288A mutation has been used in proteoliposome 
studies to maximize transport rates 1,84.  
 In order to examine the relationship between smFRET-detected conformational 
dynamics and transport, a single-molecule transport assay would be beneficial. This assay 
is currently being developed in the Blanchard laboratory, using the leucine, isoleucine, 
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valine-binding protein (LIV-BP) as a smFRET-based substrate sensor encapsulated in the 
lumen of proteoliposomes that have been reconstituted with LeuT. LIV-BP is labeled 
with fluorophores for smFRET in order to detect conformational changes that occur upon 
substrate binding. This smFRET sensor will be incorporated into smFRET studies of 
LeuT proteoliposomes using four-color FRET in order to determine which 
conformational transitions in LeuT correspond to productive substrate transport events.  
 
6.2.4 smFRET of eukaryotic NSS  
 While the overall structure of LeuT is very similar to eukaryotic NSS, as indicated 
by the crystal structures of dDAT 27,34,35, there are some differences. In dDAT, a C-
terminal helix “latch” interacts with the intracellular face in the region of the intracellular 
gate, and therefore was proposed to modulate inward-opening 27. In addition, a 
cholesterol molecule wedged between TMs 5, 7, and 1a was hypothesized to play an 
allosteric role in transport by stabilizing an outward-facing conformation, as an inward 
movement of TM1a would disrupt the cholesterol site 27. Furthermore, antidepressants 
were shown to bind to the S1 substrate site in dDAT and act as competitive inhibitors 
27,34-37, whereas they bind to the S2 site in LeuT and act as noncompetitive inhibitors 31-33. 
Thus, although the overall transport mechanism is likely very similar, some aspects of 
gating and regulation differ.  
Therefore, we propose to conduct smFRET studies of dDAT to elucidate these 
differences. Divergence between LeuT and dDAT in the effects of ligands on 
conformational dynamics may help to explain the much faster turnover rate of eukaryotic 
NSSs (~ 1 sec 23-25 versus minutes in LeuT 3,21) and their different modes of inhibition. In 
addition, as we were unable to obtain usable smFRET data with the E290S Cl--dependent 
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LeuT mutant due to poor photophysical properties, we will also examine the effect of Cl- 
on conformational dynamics in dDAT to confirm our hypotheses about the role of Cl- 
symport based on analogy to H+ antiport.  
These proposed studies will help to elucidate the eukaryotic NSS transport 
mechanism and modes of regulation in order to facilitate the design of novel modulators 
of NSS function. In addition, these studies will be an important foundation for smFRET 
studies of other eukaryotic membrane proteins, such as G-protein coupled receptors, 
which, as the targets of approximately 50% of pharmaceuticals 85, are also of great 
clinical importance.  
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APPENDIX  
 
Appendix. Unfiltered smFRET histograms. Na+ effect at the (a) intracellular and (b) 
extracellular face. Ala effect in the presence of 5 mM Na+ at the (c) intracellular and (d) 
extracellular face. Ala effect in the presence of 100 mM Li+ at the (e) intracellular and (f) 
extracellular face. 
	  
